CSNA03: sample sizes

Number of animals tested for each measure in this project, by strain and sex.       Cells with N < 5 are colored pink.


More info about these strains
CSNA03 measure Sex 129S1/SvImJ A/J C57BL/6J C57BL/6NJ CAST/EiJ CC001/UncJ CC002/UncJ CC003/UncJ CC004/TauUncJ CC005/TauUncJ CC006/TauUncJ CC007/UncJ CC008/GeniUncJ CC009/UncJ CC010/GeniUncJ CC011/UncJ CC012/GeniUncJ CC013/GeniUncJ CC015/UncJ CC016/GeniUncJ CC017/UncJ CC018/UncJ CC019/TauUncJ CC020/GeniUncJ CC023/GeniUncJ CC024/GeniUncJ CC025/GeniUncJ CC026/GeniUncJ CC027/GeniUncJ CC028/GeniUncJ CC029/UncJ CC030/GeniUncJ CC032/GeniUncJ CC033/GeniUncJ CC035/UncJ CC036/UncJ CC037/TauUncJ CC040/TauUncJ CC041/TauUncJ CC043/GeniUncJ CC044/UncJ CC045/GeniUncJ CC051/TauUncJ CC057/UncJ CC059/TauUncJ CC060/UncJ CC061/GeniUncJ CC065/UncJ CC068/TauUncJ CC074/UncJ CC075/UncJ CC078/TauUncJ CC079/TauUncJ CC080/TauUncJ CC083/UncJ CC084/TauJ DBA/2J J:DO NOD/ShiLtJ NZO/HlLtJ PWK/PhJ WSB/EiJ
dist_OFT_in   total distance traveled, 60 min test (OFT), founders   90001 (F) 48 59 61 13 33 23 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
dist_OFT_cc   total distance traveled, 60 min test (OFT), CC   90002 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
dist_perimeter_corners_OFT_in   distance traveled in perimeter and corners, 60 min test (OFT), founders   90004 (F) 48 59 61 13 33 23 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
dist_perimeter_corners_OFT_cc   distance traveled in perimeter and corners, 60 min test (OFT), CC   90005 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
dist_perimeter_corners_OFT_do   distance traveled in perimeter and corners, 60 min test (OFT), DO   90006 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
dist_perimeter_OFT_in   distance traveled in perimeter, 60 min test (OFT), founders   90007 (F) 48 59 61 13 33 23 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
dist_perimeter_OFT_cc   distance traveled in perimeter, 60 min test (OFT), CC   90008 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
dist_perimeter_OFT_do   distance traveled in perimeter, 60 min test (OFT), DO   90009 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
dist_corners_OFT_in   distance traveled in corners, 60 min test (OFT), founders   90010 (F) 48 59 61 13 33 23 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
dist_corners_OFT_cc   distance traveled in corners, 60 min test (OFT), CC   90011 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
dist_corners_OFT_do   distance traveled in corners, 60 min test (OFT), DO   90012 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
pct_dist_center_OFT_in   percentage of total distance traveled in center, 60 min test (OFT), founders   90013 (F) 48 59 61 13 33 23 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
pct_dist_center_OFT_cc   percentage of total distance traveled in center, 60 min test (OFT), CC   90014 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
pct_dist_center_OFT_do   percentage of total distance traveled in center, 60 min test (OFT), DO   90015 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
dist_slope_OFT_in   distance traveled slope, 60 min test (OFT), founders   90016 (F) 48 59 61 13 33 23 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
dist_slope_OFT_cc   distance traveled slope, 60 min test (OFT), CC   90017 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
dist_slope_OFT_do   distance traveled slope, 60 min test (OFT), DO   90018 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
amb_dist_OFT_in_bin1   distance traveled in successive 5 min intervals, 60 min test (OFT), founders , 0-5 min   90019 (F) 48 59 61 13 33 24 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
amb_dist_OFT_in_bin2   distance traveled in successive 5 min intervals, 60 min test (OFT), founders , 5-10 min   90022 (F) 48 59 61 13 33 24 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
amb_dist_OFT_in_bin3   distance traveled in successive 5 min intervals, 60 min test (OFT), founders , 10-15 min   90025 (F) 48 59 61 13 33 24 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
amb_dist_OFT_in_bin4   distance traveled in successive 5 min intervals, 60 min test (OFT), founders , 15-20 min   90028 (F) 48 59 61 13 33 23 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
amb_dist_OFT_in_bin5   distance traveled in successive 5 min intervals, 60 min test (OFT), founders , 20-25 min   90031 (F) 48 59 61 13 33 24 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
amb_dist_OFT_in_bin6   distance traveled in successive 5 min intervals, 60 min test (OFT), founders , 25-30 min   90034 (F) 48 59 61 13 33 24 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
amb_dist_OFT_in_bin7   distance traveled in successive 5 min intervals, 60 min test (OFT), founders , 30-35 min   90037 (F) 48 59 61 13 33 24 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
amb_dist_OFT_in_bin8   distance traveled in successive 5 min intervals, 60 min test (OFT), founders , 35-40 min   90040 (F) 48 59 61 13 33 24 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
amb_dist_OFT_in_bin9   distance traveled in successive 5 min intervals, 60 min test (OFT), founders , 40-45 min   90043 (F) 48 59 61 13 33 24 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
amb_dist_OFT_in_bin10   distance traveled in successive 5 min intervals, 60 min test (OFT), founders , 45-50 min   90046 (F) 48 59 61 13 33 24 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
amb_dist_OFT_in_bin11   distance traveled in successive 5 min intervals, 60 min test (OFT), founders , 50-55 min   90049 (F) 48 59 61 13 33 23 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
amb_dist_OFT_in_bin12   distance traveled in successive 5 min intervals, 60 min test (OFT), founders , 55-60 min   90052 (F) 48 59 61 13 33 23 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
amb_dist_OFT_cc_bin1   distance traveled in successive 5 min intervals, 60 min test (OFT), CC , 0-5 min   90020 (F) 48 59 61 33 16 13 12 43 18 9 7 6 7 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
amb_dist_OFT_cc_bin2   distance traveled in successive 5 min intervals, 60 min test (OFT), CC , 5-10 min   90023 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
amb_dist_OFT_cc_bin3   distance traveled in successive 5 min intervals, 60 min test (OFT), CC , 10-15 min   90026 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
amb_dist_OFT_cc_bin4   distance traveled in successive 5 min intervals, 60 min test (OFT), CC , 15-20 min   90029 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
amb_dist_OFT_cc_bin5   distance traveled in successive 5 min intervals, 60 min test (OFT), CC , 20-25 min   90032 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
amb_dist_OFT_cc_bin6   distance traveled in successive 5 min intervals, 60 min test (OFT), CC , 25-30 min   90035 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
amb_dist_OFT_cc_bin7   distance traveled in successive 5 min intervals, 60 min test (OFT), CC , 30-35 min   90038 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
amb_dist_OFT_cc_bin8   distance traveled in successive 5 min intervals, 60 min test (OFT), CC , 35-40 min   90041 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
amb_dist_OFT_cc_bin9   distance traveled in successive 5 min intervals, 60 min test (OFT), CC , 40-45 min   90044 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
amb_dist_OFT_cc_bin10   distance traveled in successive 5 min intervals, 60 min test (OFT), CC , 45-50 min   90047 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
amb_dist_OFT_cc_bin11   distance traveled in successive 5 min intervals, 60 min test (OFT), CC , 50-55 min   90050 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
amb_dist_OFT_cc_bin12   distance traveled in successive 5 min intervals, 60 min test (OFT), CC , 55-60 min   90053 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
amb_dist_OFT_do_bin1   distance traveled in successive 5 min intervals, 60 min test (OFT), DO , 0-5 min   90021 (F) 48 59 61 33 1475 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
amb_dist_OFT_do_bin2   distance traveled in successive 5 min intervals, 60 min test (OFT), DO , 5-10 min   90024 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
amb_dist_OFT_do_bin3   distance traveled in successive 5 min intervals, 60 min test (OFT), DO , 10-15 min   90027 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
amb_dist_OFT_do_bin4   distance traveled in successive 5 min intervals, 60 min test (OFT), DO , 15-20 min   90030 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
amb_dist_OFT_do_bin5   distance traveled in successive 5 min intervals, 60 min test (OFT), DO , 20-25 min   90033 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
amb_dist_OFT_do_bin6   distance traveled in successive 5 min intervals, 60 min test (OFT), DO , 25-30 min   90036 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
amb_dist_OFT_do_bin7   distance traveled in successive 5 min intervals, 60 min test (OFT), DO , 30-35 min   90039 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
amb_dist_OFT_do_bin8   distance traveled in successive 5 min intervals, 60 min test (OFT), DO , 35-40 min   90042 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
amb_dist_OFT_do_bin9   distance traveled in successive 5 min intervals, 60 min test (OFT), DO , 40-45 min   90045 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
amb_dist_OFT_do_bin10   distance traveled in successive 5 min intervals, 60 min test (OFT), DO , 45-50 min   90048 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
amb_dist_OFT_do_bin11   distance traveled in successive 5 min intervals, 60 min test (OFT), DO , 50-55 min   90051 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
amb_dist_OFT_do_bin12   distance traveled in successive 5 min intervals, 60 min test (OFT), DO , 55-60 min   90054 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
habituation_OFT_in   habituation ratio (first:last intervals), 60 min test (OFT), founders   90055 (F) 8 49 61 13 33 21 47 25 48 55
(M) 9 46 59 13 30 21 43 19 45 52
habituation_OFT_cc   habituation ratio (first:last intervals), 60 min test (OFT), CC   90056 (F) 8 49 61 33 15 8 12 43 14 9 7 6 6 6 18 23 16 3 15 14 11 19 6 11 3 11 16 20 17 10 10 10 7 14 12 10 4 20 9 8 5 12 11 14 6 10 2 5 5 9 10 5 7 4 3 47 25 48 55
(M) 9 46 59 30 15 7 13 52 10 9 7 5 6 8 20 21 15 3 16 15 13 18 8 13 3 12 16 14 15 10 10 11 5 13 12 11 7 25 8 5 6 11 11 11 5 10 6 6 3 10 6 7 4 5 43 19 45 52
time_perimeter_corners_OFT_in   time in perimeter and corners, 60 min test (OFT), founders   90100 (F) 48 59 61 13 33 23 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
time_perimeter_corners_OFT_cc   time in perimeter and corners, 60 min test (OFT), CC   90101 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
time_perimeter_corners_OFT_do   time in perimeter and corners, 60 min test (OFT), DO   90102 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
time_perimeter_OFT_in   time in perimeter, 60 min test (OFT), founders   90103 (F) 48 59 61 13 33 23 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
time_perimeter_OFT_cc   time in perimeter, 60 min test (OFT), CC   90104 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
time_perimeter_OFT_do   time in perimeter, 60 min test (OFT), DO   90105 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
time_corner_OFT_in   time in corners, 60 min test (OFT), founders   90106 (F) 48 59 61 13 33 23 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
time_corner_OFT_cc   time in corners, 60 min test (OFT), CC   90107 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
time_corner_OFT_do   time in corners, 60 min test (OFT), DO   90108 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
pct_center_time_OFT_in   percentage of total time spent in center, 60 min test (OFT), founders   90109 (F) 48 59 61 13 33 24 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
pct_center_time_OFT_cc   percentage of total time spent in center, 60 min test (OFT), CC   90110 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
pct_center_time_OFT_do   percentage of total time spent in center, 60 min test (OFT), DO   90111 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
pct_dist_perimeter_corners_OFT_in   percentage of total distance traveled in perimeter and corners, 60 min test (OFT), founders   90112 (F) 48 59 61 13 33 23 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
pct_dist_perimeter_corners_OFT_cc   percentage of total distance traveled in perimeter and corners, 60 min test (OFT), CC   90113 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
pct_dist_perimeter_corners_OFT_do   percentage of total distance traveled in perimeter and corners, 60 min test (OFT), DO   90114 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
pct_dist_perimeter_OFT_in   percentage of total distance traveled in perimeter, 60 min test (OFT), founders   90115 (F) 48 59 61 13 33 23 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
pct_dist_perimeter_OFT_cc   percentage of total distance traveled in perimeter, 60 min test (OFT), CC   90116 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
pct_dist_perimeter_OFT_do   percentage of total distance traveled in perimeter, 60 min test (OFT), DO   90117 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
pct_time_perimeter_corner_OFT_in   percentage of total time spent in perimeter and corners, 60 min test (OFT), founders   90118 (F) 48 59 61 13 33 23 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
pct_time_perimeter_corner_OFT_cc   percentage of total time spent in perimeter and corners, 60 min test (OFT), CC   90119 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
pct_time_perimeter_corner_OFT_do   percentage of total time spent in perimeter and corners, 60 min test (OFT), DO   90120 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
pct_time_perimeter_OFT_in   percentage of total time spent in perimeter, 60 min test (OFT), founders   90121 (F) 48 59 61 13 33 23 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
pct_time_perimeter_OFT_cc   percentage of total time spent in perimeter, 60 min test (OFT), CC   90122 (F) 48 59 61 33 16 13 12 43 18 9 7 6 6 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
pct_time_perimeter_OFT_do   percentage of total time spent in perimeter, 60 min test (OFT), DO   90123 (F) 48 59 61 33 1474 47 47 48 55
(M) 49 61 59 30 1383 44 46 47 52
center_time_OFT_in   time in center, 60 min test (OFT), founders   90124 (F) 48 59 61 13 33 24 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
center_time_OFT_cc   time in center, 60 min test (OFT), CC   90125 (F) 48 59 61 33 16 13 12 43 18 9 7 6 7 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
center_dist_OFT_in   distance traveled in center, 60 min test (OFT), founders   90127 (F) 48 59 61 13 33 24 47 47 48 55
(M) 49 61 59 13 30 25 44 46 47 52
center_dist_OFT_cc   distance traveled in center, 60 min test (OFT), CC   90128 (F) 48 59 61 33 16 13 12 43 18 9 7 6 7 8 19 23 17 3 15 16 12 19 6 12 3 11 16 20 17 10 10 12 7 14 12 13 5 53 9 8 5 12 11 16 6 10 2 6 5 11 10 5 10 6 9 47 47 48 55
(M) 49 61 59 30 15 15 13 53 16 10 7 5 7 9 20 22 15 3 17 16 13 18 8 13 3 12 16 16 18 10 10 13 6 13 12 12 7 66 8 6 6 12 11 17 5 10 7 6 11 10 6 8 6 10 44 46 47 52
dist_LD_in   total distance traveled, 20 min test (LD box), founders   90130 (F) 49 60 60 13 33 24 47 47 47 55
(M) 49 61 59 13 30 24 44 46 48 51
dist_LD_cc   total distance traveled, 20 min test (LD box), CC   90131 (F) 49 60 60 33 16 13 12 44 18 9 9 10 7 9 19 23 17 6 15 16 11 20 8 12 3 11 16 20 17 10 10 12 7 14 12 13 7 53 9 8 6 12 11 16 6 10 2 6 5 11 10 7 10 7 9 47 47 47 55
(M) 49 61 59 30 15 15 12 53 16 10 9 9 7 10 20 22 15 6 17 16 13 18 9 13 3 12 16 16 18 10 10 13 6 13 12 12 8 66 10 7 7 12 11 17 5 10 7 6 12 10 6 9 7 10 44 46 48 51
dist_LD_do   total distance traveled, 20 min test (LD box), DO   90132 (F) 49 60 60 33 1496 47 47 47 55
(M) 49 61 59 30 1403 44 46 48 51
dist_light_LD_in   distance traveled in light, 20 min test (LD box), founders   90133 (F) 49 60 60 13 33 24 47 47 47 55
(M) 49 61 59 13 30 24 44 46 48 51
dist_light_LD_cc   distance traveled in light, 20 min test (LD box), CC   90134 (F) 49 60 60 33 16 13 12 44 18 9 9 10 7 9 19 23 17 6 15 16 11 20 8 12 3 11 16 20 17 10 10 12 7 14 12 13 7 53 9 8 6 12 11 16 6 10 2 6 5 11 10 7 10 7 9 47 47 47 55
(M) 49 61 59 30 15 15 12 53 16 10 9 9 7 10 20 22 15 6 17 16 13 18 9 13 3 12 16 16 18 10 10 13 6 13 12 12 8 66 10 7 7 12 11 17 5 10 7 6 12 10 6 9 7 10 44 46 48 51
dist_light_LD_do   distance traveled in light, 20 min test (LD box), DO   90135 (F) 49 60 60 33 1496 47 47 47 55
(M) 49 61 59 30 1403 44 46 48 51
dist_dark_LD_in   distance traveled in dark, 20 min test (LD box), founders   90136 (F) 49 60 60 13 33 24 47 47 47 55
(M) 49 61 59 13 30 24 44 46 48 51
dist_dark_LD_cc   distance traveled in dark, 20 min test (LD box), CC   90137 (F) 49 60 60 33 16 13 12 44 18 9 9 10 7 9 19 23 17 6 15 16 11 20 8 12 3 11 16 20 17 10 10 12 7 14 12 13 7 53 9 8 6 12 11 16 6 10 2 6 5 11 10 7 10 7 9 47 47 47 55
(M) 49 61 59 30 15 15 12 53 16 10 9 9 7 10 20 22 15 6 17 16 13 18 9 13 3 12 16 16 18 10 10 13 6 13 12 12 8 66 10 7 7 12 11 17 5 10 7 6 12 10 6 9 7 10 44 46 48 51
dist_dark_LD_do   distance traveled in dark, 20 min test (LD box), DO   90138 (F) 49 60 60 33 1496 47 47 47 55
(M) 49 61 59 30 1403 44 46 48 51
pct_dist_light_LD_in   percentage of total distance traveled in light, 20 min test (LD box), founders   90139 (F) 49 60 60 13 33 24 47 47 47 55
(M) 49 61 59 13 30 24 44 46 48 51
pct_dist_light_LD_cc   percentage of total distance traveled in light, 20 min test (LD box), CC   90140 (F) 49 60 60 33 16 13 12 44 18 9 9 10 7 9 19 23 17 6 15 16 11 20 8 12 3 11 16 20 17 10 10 12 7 14 12 13 7 53 9 8 6 12 11 16 6 10 2 6 5 11 10 7 10 7 9 47 47 47 55
(M) 49 61 59 30 15 15 12 53 16 10 9 9 7 10 20 22 15 6 17 16 13 18 9 13 3 12 16 16 18 10 10 13 6 13 12 12 8 66 10 7 7 12 11 17 5 10 7 6 12 10 6 9 7 10 44 46 48 51
pct_dist_light_LD_do   percentage of total distance traveled in light, 20 min test (LD box), DO   90141 (F) 49 60 60 33 1496 47 47 47 55
(M) 49 61 59 30 1403 44 46 48 51
amb_time_tot_LD_in   total ambulatory time, 20 min test (LD box), founders   90142 (F) 49 60 60 13 33 24 47 47 47 55
(M) 49 61 59 13 30 24 44 46 48 51
amb_time_tot_LD_cc   total ambulatory time, 20 min test (LD box), CC   90143 (F) 49 60 60 33 16 13 12 44 18 9 9 10 7 9 19 23 17 6 15 16 11 20 8 12 3 11 16 20 17 10 10 12 7 14 12 13 7 53 9 8 6 12 11 16 6 10 2 6 5 11 10 7 10 7 9 47 47 47 55
(M) 49 61 59 30 15 15 12 53 16 10 9 9 7 10 20 22 15 6 17 16 13 18 9 13 3 12 16 16 18 10 10 13 6 13 12 12 8 66 10 7 7 12 11 17 5 10 7 6 12 10 6 9 7 10 44 46 48 51
amb_time_tot_LD_do   total ambulatory time, 20 min test (LD box), DO   90144 (F) 49 60 60 33 1496 47 47 47 55
(M) 49 61 59 30 1403 44 46 48 51
amb_time_light_LD_in   ambulatory time in light, 20 min test (LD box), founders   90145 (F) 49 60 60 13 33 24 47 47 47 55
(M) 49 61 59 13 30 24 44 46 48 51
amb_time_light_LD_cc   ambulatory time in light, 20 min test (LD box), CC   90146 (F) 49 60 60 33 16 13 12 44 18 9 9 10 7 9 19 23 17 6 15 16 11 20 8 12 3 11 16 20 17 10 10 12 7 14 12 13 7 53 9 8 6 12 11 16 6 10 2 6 5 11 10 7 10 7 9 47 47 47 55
(M) 49 61 59 30 15 15 12 53 16 10 9 9 7 10 20 22 15 6 17 16 13 18 9 13 3 12 16 16 18 10 10 13 6 13 12 12 8 66 10 7 7 12 11 17 5 10 7 6 12 10 6 9 7 10 44 46 48 51
amb_time_light_LD_do   ambulatory time in light, 20 min test (LD box), DO   90147 (F) 49 60 60 33 1496 47 47 47 55
(M) 49 61 59 30 1403 44 46 48 51
amb_time_dark_LD_in   ambulatory time in dark, 20 min test (LD box), founders   90148 (F) 49 60 60 13 33 24 47 47 47 55
(M) 49 61 59 13 30 24 44 46 48 51
amb_time_dark_LD_cc   ambulatory time in dark, 20 min test (LD box), CC   90149 (F) 49 60 60 33 16 13 12 44 18 9 9 10 7 9 19 23 17 6 15 16 11 20 8 12 3 11 16 20 17 10 10 12 7 14 12 13 7 53 9 8 6 12 11 16 6 10 2 6 5 11 10 7 10 7 9 47 47 47 55
(M) 49 61 59 30 15 15 12 53 16 10 9 9 7 10 20 22 15 6 17 16 13 18 9 13 3 12 16 16 18 10 10 13 6 13 12 12 8 66 10 7 7 12 11 17 5 10 7 6 12 10 6 9 7 10 44 46 48 51
amb_time_dark_LD_do   ambulatory time in dark, 20 min test (LD box), DO   90150 (F) 49 60 60 33 1496 47 47 47 55
(M) 49 61 59 30 1403 44 46 48 51
pct_amb_time_light_LD_in   percentage of time spent ambulatory in light, 20 min test (LD box), founders   90151 (F) 49 60 60 13 33 24 47 47 47 55
(M) 49 61 59 13 30 24 44 46 48 51
pct_amb_time_light_LD_cc   percentage of time spent ambulatory in light, 20 min test (LD box), CC   90152 (F) 49 60 60 33 16 13 12 44 18 9 9 10 7 9 19 23 17 6 15 16 11 20 8 12 3 11 16 20 17 10 10 12 7 14 12 13 7 53 9 8 6 12 11 16 6 10 2 6 5 11 10 7 10 7 9 47 47 47 55
(M) 49 61 59 30 15 15 12 53 16 10 9 9 7 10 20 22 15 6 17 16 13 18 9 13 3 12 16 16 18 10 10 13 6 13 12 12 8 66 10 7 7 12 11 17 5 10 7 6 12 10 6 9 7 10 44 46 48 51
pct_amb_time_light_LD_do   percentage of time spent ambulatory in light, 20 min test (LD box), DO   90153 (F) 49 60 60 33 1496 47 47 47 55
(M) 49 61 59 30 1403 44 46 48 51
pct_rest_time_light_LD_in   percentage of time resting in light, 20 min test (LD box), founders   90163 (F) 49 60 60 13 33 24 47 47 47 55
(M) 49 61 59 13 30 24 44 46 48 51
pct_rest_time_light_LD_cc   percentage of time resting in light, 20 min test (LD box), CC   90164 (F) 49 60 60 33 16 13 12 44 18 9 9 10 7 9 19 23 17 6 15 16 11 20 8 12 3 11 16 20 17 10 10 12 7 14 12 13 7 53 9 8 6 12 11 16 6 10 2 6 5 11 10 7 10 7 9 47 47 47 55
(M) 49 61 59 30 15 15 12 53 16 10 9 9 7 10 20 22 15 6 17 16 13 18 9 13 3 12 16 16 18 10 10 13 6 13 12 12 8 66 10 7 7 12 11 17 5 10 7 6 12 10 6 9 7 10 44 46 48 51
pct_rest_time_light_LD_do   percentage of time resting in light, 20 min test (LD box), DO   90165 (F) 49 60 60 33 1496 47 47 47 55
(M) 49 61 59 30 1403 44 46 48 51
time_tot_LD_in   total time, 20 min test (LD box), founders   90202 (F) 49 60 60 13 33 24 47 47 47 55
(M) 49 61 59 13 30 24 44 46 48 51
time_tot_LD_cc   total time, 20 min test (LD box), CC   90203 (F) 49 60 60 33 16 13 12 44 18 9 9 10 7 9 19 23 17 6 15 16 11 20 8 12 3 11 16 20 17 10 10 12 7 14 12 13 7 53 9 8 6 12 11 16 6 10 2 6 5 11 10 7 10 7 9 47 47 47 55
(M) 49 61 59 30 15 15 12 53 16 10 9 9 7 10 20 22 15 6 17 16 13 18 9 13 3 12 16 16 18 10 10 13 6 13 12 12 8 66 10 7 7 12 11 17 5 10 7 6 12 10 6 9 7 10 44 46 48 51
time_tot_LD_do   total time, 20 min test (LD box), DO   90204 (F) 49 60 60 33 1496 47 47 47 55
(M) 49 61 59 30 1403 44 46 48 51
time_light_LD_in   time in light, 20 min test (LD box), founders   90205 (F) 49 60 60 13 33 24 47 47 47 55
(M) 49 61 59 13 30 24 44 46 48 51
time_light_LD_cc   time in light, 20 min test (LD box), CC   90206 (F) 49 60 60 33 16 13 12 44 18 9 9 10 7 9 19 23 17 6 15 16 11 20 8 12 3 11 16 20 17 10 10 12 7 14 12 13 7 53 9 8 6 12 11 16 6 10 2 6 5 11 10 7 10 7 9 47 47 47 55
(M) 49 61 59 30 15 15 12 53 16 10 9 9 7 10 20 22 15 6 17 16 13 18 9 13 3 12 16 16 18 10 10 13 6 13 12 12 8 66 10 7 7 12 11 17 5 10 7 6 12 10 6 9 7 10 44 46 48 51
time_dark_LD_in   time in dark, 20 min test (LD box), founders   90208 (F) 49 60 60 13 33 24 47 47 47 55
(M) 49 61 59 13 30 24 44 46 48 51
time_dark_LD_cc   time in dark, 20 min test (LD box), CC   90209 (F) 49 60 60 33 16 13 12 44 18 9 9 10 7 9 19 23 17 6 15 16 11 20 8 12 3 11 16 20 17 10 10 12 7 14 12 13 7 53 9 8 6 12 11 16 6 10 2 6 5 11 10 7 10 7 9 47 47 47 55
(M) 49 61 59 30 15 15 12 53 16 10 9 9 7 10 20 22 15 6 17 16 13 18 9 13 3 12 16 16 18 10 10 13 6 13 12 12 8 66 10 7 7 12 11 17 5 10 7 6 12 10 6 9 7 10 44 46 48 51
time_dark_LD_do   time in dark, 20 min test (LD box), DO   90210 (F) 49 60 60 33 1496 47 47 47 55
(M) 49 61 59 30 1403 44 46 48 51
pct_time_light_LD_in   percentage of time in light, 20 min test (LD box), founders   90211 (F) 49 60 60 13 33 24 47 47 47 55
(M) 49 61 59 13 30 24 44 46 48 51
pct_time_light_LD_cc   percentage of time in light, 20 min test (LD box), CC   90212 (F) 49 60 60 33 16 13 12 44 18 9 9 10 7 9 19 23 17 6 15 16 11 20 8 12 3 11 16 20 17 10 10 12 7 14 12 13 7 53 9 8 6 12 11 16 6 10 2 6 5 11 10 7 10 7 9 47 47 47 55
(M) 49 61 59 30 15 15 12 53 16 10 9 9 7 10 20 22 15 6 17 16 13 18 9 13 3 12 16 16 18 10 10 13 6 13 12 12 8 66 10 7 7 12 11 17 5 10 7 6 12 10 6 9 7 10 44 46 48 51
pct_time_light_LD_do   percentage of time in light, 20 min test (LD box), DO   90213 (F) 49 60 60 33 1496 47 47 47 55
(M) 49 61 59 30 1403 44 46 48 51
amb_counts_tot_LD_in   total ambulatory counts, 20 min test (LD box), founders   90214 (F) 49 60 60 13 33 24 47 47 47 55
(M) 49 61 59 13 30 24 44 46 48 51
amb_counts_tot_LD_cc   total ambulatory counts, 20 min test (LD box), CC   90215 (F) 49 60 60 33 16 13 12 44 18 9 9 10 7 9 19 23 17 6 15 16 11 20 8 12 3 11 16 20 17 10 10 12 7 14 12 13 7 53 9 8 6 12 11 16 6 10 2 6 5 11 10 7 10 7 9 47 47 47 55
(M) 49 61 59 30 15 15 12 53 16 10 9 9 7 10 20 22 15 6 17 16 13 18 9 13 3 12 16 16 18 10 10 13 6 13 12 12 8 66 10 7 7 12 11 17 5 10 7 6 12 10 6 9 7 10 44 46 48 51
amb_counts_tot_LD_do   total ambulatory counts, 20 min test (LD box), DO   90216 (F) 49 60 60 33 1496 47 47 47 55
(M) 49 61 59 30 1403 44 46 48 51
amb_counts_light_LD_in   ambulatory counts in light, 20 min test (LD box), founders   90217 (F) 49 60 60 13 33 24 47 47 47 55
(M) 49 61 59 13 30 24 44 46 48 51
amb_counts_light_LD_cc   ambulatory counts in light, 20 min test (LD box), CC   90218 (F) 49 60 60 33 16 13 12 44 18 9 9 10 7 9 19 23 17 6 15 16 11 20 8 12 3 11 16 20 17 10 10 12 7 14 12 13 7 53 9 8 6 12 11 16 6 10 2 6 5 11 10 7 10 7 9 47 47 47 55
(M) 49 61 59 30 15 15 12 53 16 10 9 9 7 10 20 22 15 6 17 16 13 18 9 13 3 12 16 16 18 10 10 13 6 13 12 12 8 66 10 7 7 12 11 17 5 10 7 6 12 10 6 9 7 10 44 46 48 51
amb_counts_light_LD_do   ambulatory counts in light, 20 min test (LD box), DO   90219 (F) 49 60 60 33 1496 47 47 47 55
(M) 49 61 59 30 1403 44 46 48 51
amb_counts_dark_LD_in   ambulatory counts in dark, 20 min test (LD box), founders   90220 (F) 49 60 60 13 33 24 47 47 47 55
(M) 49 61 59 13 30 24 44 46 48 51
amb_counts_dark_LD_cc   ambulatory counts in dark, 20 min test (LD box), CC   90221 (F) 49 60 60 33 16 13 12 44 18 9 9 10 7 9 19 23 17 6 15 16 11 20 8 12 3 11 16 20 17 10 10 12 7 14 12 13 7 53 9 8 6 12 11 16 6 10 2 6 5 11 10 7 10 7 9 47 47 47 55
(M) 49 61 59 30 15 15 12 53 16 10 9 9 7 10 20 22 15 6 17 16 13 18 9 13 3 12 16 16 18 10 10 13 6 13 12 12 8 66 10 7 7 12 11 17 5 10 7 6 12 10 6 9 7 10 44 46 48 51
amb_counts_dark_LD_do   ambulatory counts in dark, 20 min test (LD box), DO   90222 (F) 49 60 60 33 1496 47 47 47 55
(M) 49 61 59 30 1403 44 46 48 51
pct_amb_counts_light_LD_in   percentage of ambulatory counts in light, 20 min test (LD box), founders   90223 (F) 48 60 60 13 33 24 47 47 47 55
(M) 49 61 59 13 30 24 44 46 48 51
pct_amb_counts_light_LD_cc   percentage of ambulatory counts in light, 20 min test (LD box), CC   90224 (F) 48 60 60 33 16 13 12 44 18 9 9 10 7 9 19 23 17 6 15 16 11 20 8 12 3 11 16 20 17 10 10 12 7 14 12 13 7 53 9 8 6 12 11 16 6 10 2 6 5 11 10 7 10 7 9 47 47 47 55
(M) 49 61 59 30 15 15 12 53 16 10 9 9 7 10 20 22 15 6 17 16 13 18 9 13 3 12 16 16 18 10 10 13 6 13 12 12 8 66 10 7 7 12 11 17 5 10 7 6 12 10 6 9 7 10 44 46 48 51
pct_amb_counts_light_LD_do   percentage of ambulatory counts in light, 20 min test (LD box), DO   90225 (F) 48 60 60 33 1496 47 47 47 55
(M) 49 61 59 30 1403 44 46 48 51
light_dark_transitions_LD_in   total number of light-dark transitions, 20 min test (LD box), founders   90262 (F) 49 60 60 13 33 24 47 47 47 55
(M) 49 61 59 13 30 24 44 46 48 51
light_dark_transitions_LD_cc   total number of light-dark transitions, 20 min test (LD box), CC   90263 (F) 49 60 60 33 16 13 12 44 18 9 9 10 7 9 19 23 17 6 15 16 11 20 8 12 3 11 16 20 17 10 10 12 7 14 12 13 7 53 9 8 6 12 11 16 6 10 2 6 5 11 10 7 10 7 9 47 47 47 55
(M) 49 61 59 30 15 15 12 53 16 10 9 9 7 10 20 22 15 6 17 16 13 18 9 13 3 12 16 16 18 10 10 13 6 13 12 12 8 66 10 7 7 12 11 17 5 10 7 6 12 10 6 9 7 10 44 46 48 51
light_dark_transitions_LD_do   total number of light-dark transitions, 20 min test (LD box), DO   90264 (F) 49 60 60 33 1496 47 47 47 55
(M) 49 61 59 30 1403 44 46 48 51
entries_total_HB_in   total number of entries (hole board), founders   90265 (F) 41 48 61 12 33 24 42 43 48 51
(M) 45 56 58 12 30 23 42 43 47 49
entries_total_HB_cc   total number of entries (hole board), CC   90266 (F) 41 48 61 33 16 13 11 39 17 10 10 11 10 7 18 20 16 8 15 16 11 20 8 12 5 11 16 18 16 10 8 12 9 13 11 13 12 48 10 8 6 12 10 16 6 10 2 10 9 10 10 7 8 7 9 42 43 48 51
(M) 45 56 58 30 15 14 12 51 14 11 7 8 10 5 19 22 15 9 17 16 13 18 9 13 6 12 16 16 17 9 10 12 7 13 11 12 12 60 10 7 7 12 10 17 6 9 10 9 12 9 9 10 7 10 42 43 47 49
entries_total_HB_do   total number of entries (hole board), DO   90267 (F) 41 48 61 33 1413 42 43 48 51
(M) 45 56 58 30 1319 42 43 47 49
entries_novel_HB_in   number of novel entries (hole board), founders   90268 (F) 41 48 61 12 33 24 42 43 48 51
(M) 45 56 58 12 30 23 42 43 47 49
entries_novel_HB_cc   number of novel entries (hole board), CC   90269 (F) 41 48 61 33 16 13 11 39 17 10 10 11 10 7 18 20 16 8 15 16 11 20 8 12 5 11 16 18 16 10 8 12 9 13 11 13 12 48 10 8 6 12 10 16 6 10 2 10 9 10 10 7 8 7 9 42 43 48 51
(M) 45 56 58 30 15 14 12 51 14 11 7 8 10 5 19 22 15 9 17 16 13 18 9 13 6 12 16 16 17 9 10 12 7 13 11 12 12 60 10 7 7 12 10 17 6 9 10 9 12 9 9 10 7 10 42 43 47 49
entries_novel_HB_do   number of novel entries (hole board), DO   90270 (F) 41 48 61 33 1413 42 43 48 51
(M) 45 56 58 30 1319 42 43 47 49
entries_repeat_HB_in   number of repeat entries (hole board), founders   90271 (F) 41 48 61 12 33 24 42 43 48 51
(M) 45 56 58 12 30 23 42 43 47 49
entries_repeat_HB_cc   number of repeat entries (hole board), CC   90272 (F) 41 48 61 33 16 13 11 39 17 10 10 11 10 7 18 20 16 8 15 16 11 20 8 12 5 11 16 18 16 10 8 12 9 13 11 13 12 48 10 8 6 12 10 16 6 10 2 10 9 10 10 7 8 7 9 42 43 48 51
(M) 45 56 58 30 15 14 12 51 14 11 7 8 10 5 19 22 15 9 17 16 13 18 9 13 6 12 16 16 17 9 10 12 7 13 11 12 12 60 10 7 7 12 10 17 6 9 10 9 12 9 9 10 7 10 42 43 47 49
entries_repeat_HB_do   number of repeat entries (hole board), DO   90273 (F) 41 48 61 33 1413 42 43 48 51
(M) 45 56 58 30 1319 42 43 47 49
time_wo_gray_in   percentage of time spent in novel zone, excluding center gray zone (novelty preference), founders   90286 (F) 42 60 58 9 31 24 42 44 43 51
(M) 45 61 55 10 28 23 39 43 42 47
time_wo_gray_cc   percentage of time spent in novel zone, excluding center gray zone (novelty preference), CC   90287 (F) 42 60 58 31 15 11 12 41 15 10 8 7 8 6 17 19 17 3 15 16 10 20 4 12 5 11 16 18 12 9 10 12 6 13 11 12 9 42 10 8 5 11 6 16 5 10 2 11 8 10 9 5 10 6 10 42 44 43 51
(M) 45 61 55 28 14 13 13 49 15 11 7 6 9 8 18 20 15 4 17 16 11 18 4 12 6 12 16 16 15 10 10 13 5 12 12 12 11 57 9 5 6 12 7 15 6 9 14 10 10 9 9 10 6 9 39 43 42 47
time_wo_gray_do   percentage of time spent in novel zone, excluding center gray zone (novelty preference), DO   90288 (F) 42 60 58 31 1387 42 44 43 51
(M) 45 61 55 28 1298 39 43 42 47
time_w_gray_in   percentage of time spent in novel zone, including center gray zone (novelty preference), founders   90289 (F) 42 60 58 9 31 24 42 44 43 51
(M) 45 61 55 10 28 23 39 43 42 47
time_w_gray_cc   percentage of time spent in novel zone, including center gray zone (novelty preference), CC   90290 (F) 42 60 58 31 15 11 12 41 15 10 8 7 8 6 17 19 17 3 15 16 10 20 4 12 5 11 16 18 12 9 10 12 6 13 11 12 9 42 10 8 5 11 6 16 5 10 2 11 8 10 9 5 10 6 10 42 44 43 51
(M) 45 61 55 28 14 13 13 49 15 11 7 6 9 8 18 20 15 4 17 16 11 18 4 12 6 12 16 16 15 10 10 13 5 12 12 12 11 57 9 5 6 12 7 15 6 9 14 10 10 9 9 10 6 9 39 43 42 47
time_w_gray_do   percentage of time spent in novel zone, including center gray zone (novelty preference), DO   90291 (F) 42 60 58 31 1388 42 44 43 51
(M) 45 61 55 28 1298 39 43 42 47
dist_d3_d2_cont_in   distance traveled, last 60 min (post-injection), Day 3 minus Day 2, saline control, founders   90304 (F) 8 6 7 5 3 4 10 8 7
(M) 8 8 5 7 2 5 9 7 7
dist_d3_d2_cont_cc   distance traveled, last 60 min (post-injection), Day 3 minus Day 2, saline control, CC   90305 (F) 8 6 7 5 4 3 3 11 3 2 1 1 2 1 4 4 4 4 4 2 5 2 3 2 4 3 3 2 3 2 2 3 3 3 2 19 2 1 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 4 10 8 7
(M) 8 8 5 7 4 3 3 11 3 2 2 1 2 2 4 4 4 1 4 4 2 5 2 3 2 4 3 3 2 3 2 1 2 3 3 3 19 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 7 7
dist_d3_d2_cont_do   distance traveled, last 60 min (post-injection), Day 3 minus Day 2, saline control, DO   90306 (F) 8 6 7 5 181 4 10 8 7
(M) 8 8 5 7 182 5 9 7 7
dist_d3_d2_cocaine_in   distance traveled, last 60 min (post-injection), Day 3 (cocaine) minus Day 2 (saline), cocaine sensitization, founders   90307 (F) 6 12 5 1 6 2 6 6 9 7
(M) 6 11 6 1 5 4 6 7 9 7
dist_d3_d2_cocaine_cc   distance traveled, last 60 min (post-injection), Day 3 (cocaine) minus Day 2 (saline), cocaine sensitization, CC   90308 (F) 6 12 5 6 4 3 3 18 2 2 2 3 2 2 4 4 5 2 4 4 2 4 2 3 2 4 3 3 2 3 3 2 3 3 3 3 18 2 2 2 2 2 3 1 2 1 2 2 2 2 2 2 2 2 6 6 9 7
(M) 6 11 6 5 4 3 3 19 2 2 2 3 2 2 4 4 3 1 4 4 2 5 2 3 2 4 3 3 2 3 3 3 3 3 3 2 17 2 2 2 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 9 7
dist_d3_d2_cocaine_do   distance traveled, last 60 min (post-injection), Day 3 (cocaine) minus Day 2 (saline), cocaine sensitization, DO   90309 (F) 6 12 5 6 185 6 6 9 7
(M) 6 11 6 5 191 6 7 9 7
dist_d5_d3_cont_in   distance traveled, last 60 min (post-injection), Day 5 minus Day 3, saline control, founders   90310 (F) 8 7 7 6 3 5 9 8 6
(M) 8 8 5 6 2 5 9 7 7
dist_d5_d3_cont_cc   distance traveled, last 60 min (post-injection), Day 5 minus Day 3, saline control, CC   90311 (F) 8 7 7 6 4 3 3 11 3 2 1 1 2 1 4 4 4 3 4 2 5 2 3 2 4 3 3 2 3 2 2 2 3 3 2 19 2 1 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 5 9 8 6
(M) 8 8 5 6 4 3 2 11 3 2 2 1 2 2 4 4 4 1 4 4 2 5 2 3 2 2 3 3 2 3 2 1 2 3 3 3 19 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 7 7
dist_d5_d3_cont_do   distance traveled, last 60 min (post-injection), Day 5 minus Day 3, saline control, DO   90312 (F) 8 7 7 6 180 5 9 8 6
(M) 8 8 5 6 182 5 9 7 7
dist_d5_d3_cocaine_in   distance traveled, last 60 min (post-injection), Day 5 (cocaine) minus Day 3 (cocaine), cocaine sensitization, founders   90313 (F) 6 12 5 1 6 2 6 6 9 7
(M) 6 12 7 1 5 4 6 7 9 7
dist_d5_d3_cocaine_cc   distance traveled, last 60 min (post-injection), Day 5 (cocaine) minus Day 3 (cocaine), cocaine sensitization, CC   90314 (F) 6 12 5 6 4 3 2 17 2 2 2 3 2 2 4 2 5 2 4 4 2 4 2 3 2 4 3 2 2 3 3 2 3 3 3 3 18 2 2 2 2 2 3 1 2 1 2 2 2 2 2 2 2 2 6 6 9 7
(M) 6 12 7 5 4 3 3 19 2 2 2 3 2 2 4 3 3 1 3 4 2 5 2 3 2 4 3 2 2 3 3 3 3 3 3 2 17 2 2 2 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 9 7
dist_d5_d3_cocaine_do   distance traveled, last 60 min (post-injection), Day 5 (cocaine) minus Day 3 (cocaine), cocaine sensitization, DO   90315 (F) 6 12 5 6 184 6 6 9 7
(M) 6 12 7 5 190 6 7 9 7
dist_d12_d2_cont_in   distance traveled, last 60 min (post-injection), Day 12 minus Day 2, saline control, founders   90316 (F) 8 5 7 6 3 4 10 8 7
(M) 8 8 6 7 2 5 9 7 6
dist_d12_d2_cont_cc   distance traveled, last 60 min (post-injection), Day 12 minus Day 2, saline control, CC   90317 (F) 8 5 7 6 4 3 3 11 3 2 1 1 2 1 4 4 4 4 4 2 5 2 3 2 4 3 3 2 3 2 2 3 3 3 2 19 2 1 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 4 10 8 7
(M) 8 8 6 7 4 3 3 11 3 2 2 1 2 2 4 4 4 1 4 4 2 5 2 3 2 3 3 2 2 3 2 1 2 3 3 3 19 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 7 6
dist_d12_d2_cont_do   distance traveled, last 60 min (post-injection), Day 12 minus Day 2, saline control, DO   90318 (F) 8 5 7 6 179 4 10 8 7
(M) 8 8 6 7 181 5 9 7 6
dist_d12_d2_cocaine_in   distance traveled, last 60 min (post-injection), Day 12 (saline) minus Day 2 (saline), cocaine sensitization, founders   90319 (F) 6 12 5 1 6 3 6 6 8 7
(M) 6 11 6 1 5 4 6 7 7 7
dist_d12_d2_cocaine_cc   distance traveled, last 60 min (post-injection), Day 12 (saline) minus Day 2 (saline), cocaine sensitization, CC   90320 (F) 6 12 5 6 4 3 3 19 2 2 2 3 2 2 4 4 5 2 4 4 2 4 2 3 2 4 3 3 2 3 3 2 3 3 3 3 20 2 2 2 2 2 3 1 2 1 2 2 2 2 2 2 2 2 6 6 8 7
(M) 6 11 6 5 4 3 3 20 2 2 2 3 2 2 4 4 3 1 4 4 2 5 2 3 2 4 3 3 2 3 3 3 3 3 3 2 20 2 2 2 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 7 7
dist_d12_d2_cocaine_do   distance traveled, last 60 min (post-injection), Day 12 (saline) minus Day 2 (saline), cocaine sensitization, DO   90321 (F) 6 12 5 6 184 6 6 8 7
(M) 6 11 6 5 188 6 7 7 7
dist_d19_d11_cont_in   distance traveled, last 60 min (post-injection), Day 19 minus Day 11, saline control, founders   90322 (F) 8 5 7 7 3 5 10 8 6
(M) 8 8 6 7 2 5 9 8 7
dist_d19_d11_cont_cc   distance traveled, last 60 min (post-injection), Day 19 minus Day 11, saline control, CC   90323 (F) 8 5 7 7 4 3 3 7 3 1 1 1 2 1 3 4 4 4 3 2 5 2 3 2 4 3 2 2 3 2 2 3 3 3 2 16 2 2 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 5 10 8 6
(M) 8 8 6 7 4 3 3 9 3 2 2 1 2 2 4 4 4 1 4 3 2 5 2 3 2 3 3 1 2 3 2 1 2 3 3 3 15 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 8 7
dist_d19_d11_cont_do   distance traveled, last 60 min (post-injection), Day 19 minus Day 11, saline control, DO   90324 (F) 8 5 7 7 140 5 10 8 6
(M) 8 8 6 7 145 5 9 8 7
dist_d19_d11_cocaine_in   distance traveled, last 60 min (post-injection), Day 19 (cocaine) minus Day 11 (cocaine), cocaine sensitization, founders   90325 (F) 5 11 5 1 6 3 6 5 9 7
(M) 6 12 7 1 5 4 6 7 9 7
dist_d19_d11_cocaine_cc   distance traveled, last 60 min (post-injection), Day 19 (cocaine) minus Day 11 (cocaine), cocaine sensitization, CC   90326 (F) 5 11 5 6 4 3 3 17 2 1 2 3 2 2 4 4 5 2 4 3 2 4 2 3 2 4 3 2 2 3 3 2 3 3 3 3 15 2 2 1 2 2 3 1 2 1 2 2 2 2 2 2 2 2 6 5 9 7
(M) 6 12 7 5 4 3 3 16 2 1 2 3 2 1 4 4 3 1 4 3 2 5 2 3 2 4 3 2 2 3 3 3 3 3 2 2 18 2 2 1 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 9 7
dist_d19_d11_cocaine_do   distance traveled, last 60 min (post-injection), Day 19 (cocaine) minus Day 11 (cocaine), cocaine sensitization, DO   90327 (F) 5 11 5 6 146 6 5 9 7
(M) 6 12 7 5 147 6 7 9 7
dist_d3_d11_auc_cont_in   distance traveled, last 60 min (post-injection), Day 3 to Day 11 AUC, saline control, founders   90437 (F) 8 5 7 7 3 4 9 8 7
(M) 8 8 5 7 2 5 9 7 7
dist_d3_d11_auc_cont_cc   distance traveled, last 60 min (post-injection), Day 3 to Day 11 AUC, saline control, CC   90438 (F) 8 5 7 7 4 3 3 7 3 1 1 1 2 1 3 4 4 3 3 2 5 2 3 2 4 2 2 2 3 2 2 2 3 3 2 16 2 1 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 4 9 8 7
(M) 8 8 5 7 4 3 2 8 3 2 2 1 2 2 4 4 4 1 4 3 2 5 2 3 2 2 3 1 2 3 2 1 2 3 3 3 14 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 7 7
dist_d3_d11_auc_cont_do   distance traveled, last 60 min (post-injection), Day 3 to Day 11 AUC, saline control, DO   90439 (F) 8 5 7 7 129 4 9 8 7
(M) 8 8 5 7 131 5 9 7 7
dist_d3_d11_auc_cocaine_in   distance traveled, last 60 min (post-injection), Day 3 (cocaine) to Day 11 (cocaine) AUC, cocaine sensitization, founders   90440 (F) 6 11 4 1 6 2 6 5 9 7
(M) 6 12 7 1 5 4 6 7 9 7
dist_d3_d11_auc_cocaine_cc   distance traveled, last 60 min (post-injection), Day 3 (cocaine) to Day 11 (cocaine) AUC, cocaine sensitization, CC   90441 (F) 6 11 4 6 3 3 2 15 2 1 2 3 2 2 4 2 5 2 4 2 2 4 2 3 2 4 3 2 2 3 3 2 3 3 3 3 13 2 2 1 2 2 3 1 2 1 2 2 2 2 2 2 2 2 6 5 9 7
(M) 6 12 7 5 4 3 3 15 2 1 2 3 2 1 4 3 3 1 3 3 2 5 2 3 2 4 3 1 2 3 3 3 3 3 2 2 16 2 2 1 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 9 7
dist_d3_d11_auc_cocaine_do   distance traveled, last 60 min (post-injection), Day 3 (cocaine) to Day 11 (cocaine) AUC, cocaine sensitization, DO   90442 (F) 6 11 4 6 131 6 5 9 7
(M) 6 12 7 5 133 6 7 9 7
dist_f30_cont_in_d1   distance traveled, first 30 min (pre-injection), on successive days, saline group, founders , day 1   90328 (F) 8 7 7 7 3 5 10 8 7
(M) 8 8 6 7 3 5 9 8 7
dist_f30_cont_in_d2   distance traveled, first 30 min (pre-injection), on successive days, saline group, founders , day 2   90334 (F) 8 6 7 7 3 5 10 8 7
(M) 8 8 6 7 2 5 9 7 7
dist_f30_cont_in_d3   distance traveled, first 30 min (pre-injection), on successive days, saline group, founders , day 3   90340 (F) 8 7 7 7 3 5 10 8 7
(M) 8 8 5 7 2 5 9 8 7
dist_f30_cont_in_d5   distance traveled, first 30 min (pre-injection), on successive days, saline group, founders , day 5   90346 (F) 8 7 7 7 3 5 10 8 7
(M) 8 8 6 7 2 5 9 7 7
dist_f30_cont_in_d7   distance traveled, first 30 min (pre-injection), on successive days, saline group, founders , day 7   90352 (F) 8 7 7 7 3 5 10 8 7
(M) 8 8 6 7 2 5 9 8 7
dist_f30_cont_in_d9   distance traveled, first 30 min (pre-injection), on successive days, saline group, founders , day 9   90358 (F) 8 7 7 7 3 5 10 8 7
(M) 8 8 6 7 2 5 9 8 7
dist_f30_cont_in_d11   distance traveled, first 30 min (pre-injection), on successive days, saline group, founders , day 11   90364 (F) 8 5 7 7 3 5 10 8 7
(M) 8 8 6 7 2 5 9 8 7
dist_f30_cont_in_d12   distance traveled, first 30 min (pre-injection), on successive days, saline group, founders , day 12   90370 (F) 8 6 7 7 3 5 10 8 7
(M) 8 8 6 7 2 5 9 8 7
dist_f30_cont_in_d19   distance traveled, first 30 min (pre-injection), on successive days, saline group, founders , day 19   90376 (F) 8 6 7 7 3 5 10 8 7
(M) 8 8 6 7 2 5 9 8 7
dist_f30_cont_cc_d1   distance traveled, first 30 min (pre-injection), on successive days, saline group, CC , day 1   90329 (F) 8 7 7 7 4 3 3 8 3 2 1 1 2 1 3 4 4 4 4 2 5 2 3 2 4 3 3 2 3 2 2 3 3 3 2 17 2 2 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 5 10 8 7
(M) 8 8 6 7 4 3 3 9 3 2 2 1 2 2 4 4 4 1 4 4 2 5 2 3 2 4 3 3 2 3 2 1 2 3 3 3 19 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 8 7
dist_f30_cont_cc_d2   distance traveled, first 30 min (pre-injection), on successive days, saline group, CC , day 2   90335 (F) 8 6 7 7 4 3 3 11 3 2 1 1 2 1 4 4 4 4 4 2 5 2 3 2 4 3 3 2 3 2 2 3 3 3 2 19 2 1 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 5 10 8 7
(M) 8 8 6 7 4 3 3 11 3 2 2 1 2 2 4 4 4 1 4 4 2 5 2 3 2 4 3 3 2 3 2 1 2 3 3 3 20 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 7 7
dist_f30_cont_cc_d3   distance traveled, first 30 min (pre-injection), on successive days, saline group, CC , day 3   90341 (F) 8 7 7 7 4 3 3 11 3 2 1 1 2 1 4 4 4 4 4 2 5 2 3 2 4 3 3 2 3 2 2 3 3 3 2 19 2 2 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 5 10 8 7
(M) 8 8 5 7 4 3 3 11 3 2 2 1 2 2 4 4 4 1 4 4 2 5 2 3 2 4 3 3 2 3 2 1 2 3 3 3 20 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 8 7
dist_f30_cont_cc_d5   distance traveled, first 30 min (pre-injection), on successive days, saline group, CC , day 5   90347 (F) 8 7 7 7 4 3 3 11 3 2 1 1 2 1 4 4 4 3 4 2 5 2 3 2 4 3 3 2 3 2 2 2 3 3 2 19 2 1 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 5 10 8 7
(M) 8 8 6 7 4 3 2 11 3 2 2 1 2 2 4 4 4 1 4 4 2 5 2 3 2 2 3 3 2 3 2 1 2 3 3 3 20 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 7 7
dist_f30_cont_cc_d7   distance traveled, first 30 min (pre-injection), on successive days, saline group, CC , day 7   90353 (F) 8 7 7 7 4 3 3 11 3 2 1 1 2 1 4 4 4 4 4 2 5 2 3 2 4 3 3 2 3 2 2 3 3 3 2 19 2 2 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 5 10 8 7
(M) 8 8 6 7 4 3 3 11 3 2 2 1 2 2 4 4 4 1 4 4 2 5 2 3 2 4 3 3 2 3 2 1 2 3 3 3 20 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 8 7
dist_f30_cont_cc_d9   distance traveled, first 30 min (pre-injection), on successive days, saline group, CC , day 9   90359 (F) 8 7 7 7 4 3 3 11 3 2 1 1 2 1 4 4 4 4 4 2 5 2 3 2 4 2 3 2 3 2 2 3 3 3 2 19 2 1 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 5 10 8 7
(M) 8 8 6 7 4 3 3 10 3 2 2 1 2 2 4 4 4 1 4 4 2 5 2 3 2 4 3 2 2 3 2 1 2 3 3 3 18 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 8 7
dist_f30_cont_cc_d11   distance traveled, first 30 min (pre-injection), on successive days, saline group, CC , day 11   90365 (F) 8 5 7 7 4 3 3 7 3 1 1 1 2 1 3 4 4 4 3 2 5 2 3 2 4 3 2 2 3 2 2 3 3 3 2 16 2 2 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 5 10 8 7
(M) 8 8 6 7 4 3 3 9 3 2 2 1 2 2 4 4 4 1 4 3 2 5 2 3 2 4 3 1 2 3 2 1 2 3 3 3 15 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 8 7
dist_f30_cont_cc_d12   distance traveled, first 30 min (pre-injection), on successive days, saline group, CC , day 12   90371 (F) 8 6 7 7 4 3 3 11 3 2 1 1 2 1 4 4 4 4 4 2 5 2 3 2 4 3 3 2 3 2 2 3 3 3 2 19 2 2 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 5 10 8 7
(M) 8 8 6 7 4 3 3 11 3 2 2 1 2 2 4 4 4 1 4 4 2 5 2 3 2 3 3 2 2 3 2 1 2 3 3 3 19 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 8 7
dist_f30_cont_cc_d19   distance traveled, first 30 min (pre-injection), on successive days, saline group, CC , day 19   90377 (F) 8 6 7 7 4 3 3 11 3 2 1 1 2 1 4 4 4 4 4 2 5 2 3 2 4 3 3 2 3 2 2 3 3 3 2 19 2 2 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 5 10 8 7
(M) 8 8 6 7 4 3 3 11 3 2 2 1 2 2 4 4 4 1 4 4 2 5 2 3 2 3 3 2 2 3 2 1 2 3 3 3 19 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 8 7
dist_f30_cont_do_d1   distance traveled, first 30 min (pre-injection), on successive days, saline group, DO , day 1   90330 (F) 8 7 7 7 176 5 10 8 7
(M) 8 8 6 7 178 5 9 8 7
dist_f30_cont_do_d2   distance traveled, first 30 min (pre-injection), on successive days, saline group, DO , day 2   90336 (F) 8 6 7 7 182 5 10 8 7
(M) 8 8 6 7 183 5 9 7 7
dist_f30_cont_do_d3   distance traveled, first 30 min (pre-injection), on successive days, saline group, DO , day 3   90342 (F) 8 7 7 7 181 5 10 8 7
(M) 8 8 5 7 184 5 9 8 7
dist_f30_cont_do_d5   distance traveled, first 30 min (pre-injection), on successive days, saline group, DO , day 5   90348 (F) 8 7 7 7 181 5 10 8 7
(M) 8 8 6 7 182 5 9 7 7
dist_f30_cont_do_d7   distance traveled, first 30 min (pre-injection), on successive days, saline group, DO , day 7   90354 (F) 8 7 7 7 182 5 10 8 7
(M) 8 8 6 7 183 5 9 8 7
dist_f30_cont_do_d9   distance traveled, first 30 min (pre-injection), on successive days, saline group, DO , day 9   90360 (F) 8 7 7 7 170 5 10 8 7
(M) 8 8 6 7 170 5 9 8 7
dist_f30_cont_do_d11   distance traveled, first 30 min (pre-injection), on successive days, saline group, DO , day 11   90366 (F) 8 5 7 7 143 5 10 8 7
(M) 8 8 6 7 147 5 9 8 7
dist_f30_cont_do_d12   distance traveled, first 30 min (pre-injection), on successive days, saline group, DO , day 12   90372 (F) 8 6 7 7 179 5 10 8 7
(M) 8 8 6 7 183 5 9 8 7
dist_f30_cont_do_d19   distance traveled, first 30 min (pre-injection), on successive days, saline group, DO , day 19   90378 (F) 8 6 7 7 181 5 10 8 7
(M) 8 8 6 7 182 5 9 8 7
dist_f30_cocaine_in_d1   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders , day 1   90331 (F) 6 12 6 1 6 3 6 6 9 7
(M) 6 12 7 1 5 4 6 7 9 7
dist_f30_cocaine_in_d2   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders , day 2   90337 (F) 6 12 6 1 6 3 6 6 9 7
(M) 6 12 6 1 5 4 6 7 9 7
dist_f30_cocaine_in_d3   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders , day 3   90343 (F) 6 12 5 1 6 2 6 6 9 7
(M) 6 12 7 1 5 4 6 7 9 7
dist_f30_cocaine_in_d5   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders , day 5   90349 (F) 6 12 6 1 6 3 6 6 9 7
(M) 6 12 7 1 5 4 6 7 9 7
dist_f30_cocaine_in_d7   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders , day 7   90355 (F) 6 12 5 1 6 3 6 6 9 7
(M) 6 12 7 1 5 4 6 7 9 7
dist_f30_cocaine_in_d9   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders , day 9   90361 (F) 6 12 5 1 6 3 6 6 9 7
(M) 6 12 7 1 5 4 6 7 9 7
dist_f30_cocaine_in_d11   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders , day 11   90367 (F) 6 11 6 1 6 3 6 6 9 7
(M) 6 12 7 1 5 4 6 7 9 7
dist_f30_cocaine_in_d12   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders , day 12   90373 (F) 6 12 5 1 6 3 6 6 9 7
(M) 6 12 7 1 5 4 6 7 8 7
dist_f30_cocaine_in_d19   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders , day 19   90379 (F) 6 12 5 1 6 3 6 6 9 7
(M) 6 12 7 1 5 4 6 7 9 7
dist_f30_cocaine_cc_d1   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, CC , day 1   90332 (F) 6 12 6 6 4 3 3 17 2 2 2 3 2 2 4 4 5 2 4 4 2 4 2 3 2 4 3 3 2 3 3 2 3 3 3 3 18 2 2 2 2 2 3 1 3 1 2 2 2 2 2 2 2 2 6 6 9 7
(M) 6 12 7 5 4 3 3 17 2 2 2 3 1 2 4 4 3 1 4 4 2 5 2 3 2 4 3 3 2 3 3 3 3 3 3 2 19 2 2 2 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 9 7
dist_f30_cocaine_cc_d2   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, CC , day 2   90338 (F) 6 12 6 6 4 3 3 19 2 2 2 3 2 2 4 4 5 2 4 4 2 4 2 3 2 4 3 3 2 3 3 2 3 3 3 3 20 2 2 2 2 2 3 1 3 1 2 2 2 2 2 2 2 2 6 6 9 7
(M) 6 12 6 5 4 3 3 20 2 2 2 3 2 2 4 4 3 1 4 4 2 5 2 3 2 4 3 3 2 3 3 3 3 3 3 2 20 2 2 2 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 9 7
dist_f30_cocaine_cc_d3   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, CC , day 3   90344 (F) 6 12 5 6 4 3 3 18 2 2 2 3 2 2 4 4 5 2 4 4 2 4 2 3 2 4 3 3 2 3 3 2 3 3 3 3 18 2 2 2 2 2 3 1 3 1 2 2 2 2 2 2 2 2 6 6 9 7
(M) 6 12 7 5 4 3 3 19 2 2 2 3 2 2 4 4 3 1 4 4 2 5 2 3 2 4 3 3 2 3 3 3 3 3 3 2 18 2 2 2 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 9 7
dist_f30_cocaine_cc_d5   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, CC , day 5   90350 (F) 6 12 6 6 4 3 2 18 2 2 2 3 2 2 4 2 5 2 4 4 2 4 2 3 2 4 3 3 2 3 3 2 3 3 3 3 20 2 2 2 2 2 3 1 2 1 2 2 2 2 2 2 2 2 6 6 9 7
(M) 6 12 7 5 4 3 3 20 2 2 2 3 2 2 4 3 3 1 3 4 2 5 2 3 2 4 3 2 2 3 3 3 3 3 3 2 20 2 2 2 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 9 7
dist_f30_cocaine_cc_d7   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, CC , day 7   90356 (F) 6 12 5 6 4 3 3 19 2 2 2 3 2 2 4 4 5 2 4 4 2 4 2 3 2 4 3 3 2 3 3 2 3 3 3 3 20 2 2 2 2 2 3 1 2 1 2 2 2 2 2 2 2 2 6 6 9 7
(M) 6 12 7 5 4 3 3 20 2 2 2 3 2 2 4 4 3 1 4 4 2 5 2 3 2 4 3 3 2 3 3 3 3 3 3 2 20 2 2 2 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 9 7
dist_f30_cocaine_cc_d9   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, CC , day 9   90362 (F) 6 12 5 6 4 3 3 19 2 2 2 3 2 2 4 4 5 2 4 4 2 4 2 3 2 4 3 3 2 3 3 2 3 3 3 3 20 2 2 2 2 2 3 1 2 1 2 2 2 2 2 2 2 2 6 6 9 7
(M) 6 12 7 5 4 3 3 20 2 2 2 3 2 2 4 4 3 1 4 4 2 5 2 3 2 4 3 3 2 3 3 3 3 3 3 2 20 2 2 2 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 9 7
dist_f30_cocaine_cc_d11   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, CC , day 11   90368 (F) 6 11 6 6 4 3 3 17 2 1 2 3 2 2 4 4 5 2 4 3 2 4 2 3 2 4 3 2 2 3 3 2 3 3 3 3 16 2 2 1 2 2 3 1 2 1 2 2 2 2 2 2 2 2 6 6 9 7
(M) 6 12 7 5 4 3 3 16 2 1 2 3 2 2 4 4 3 1 4 3 2 5 2 3 2 4 3 2 2 3 3 3 3 3 3 2 19 2 2 1 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 9 7
dist_f30_cocaine_cc_d12   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, CC , day 12   90374 (F) 6 12 5 6 4 3 3 19 2 2 2 3 2 2 4 4 5 2 4 4 2 4 2 3 2 4 3 3 2 3 3 2 3 3 3 3 20 2 2 2 2 2 3 1 2 1 2 2 2 2 2 2 2 2 6 6 9 7
(M) 6 12 7 5 4 3 3 20 2 2 2 3 2 2 4 4 3 1 4 4 2 5 2 3 2 4 3 3 2 3 3 3 3 3 3 2 20 2 2 2 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 8 7
dist_f30_cocaine_cc_d19   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, CC , day 19   90380 (F) 6 12 5 6 4 3 3 19 2 2 2 3 2 2 4 4 5 2 4 4 2 4 2 3 2 4 3 2 2 3 3 2 3 3 3 3 20 2 2 2 2 2 3 1 2 1 2 2 2 2 2 2 2 2 6 6 9 7
(M) 6 12 7 5 4 3 3 20 2 2 2 3 2 2 4 4 3 1 4 4 2 5 2 3 2 4 3 3 2 3 3 3 3 3 3 2 20 2 2 2 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 9 7
dist_f30_cocaine_do_d1   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO , day 1   90333 (F) 6 12 6 6 183 6 6 9 7
(M) 6 12 7 5 187 6 7 9 7
dist_f30_cocaine_do_d2   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO , day 2   90339 (F) 6 12 6 6 186 6 6 9 7
(M) 6 12 6 5 192 6 7 9 7
dist_f30_cocaine_do_d3   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO , day 3   90345 (F) 6 12 5 6 187 6 6 9 7
(M) 6 12 7 5 193 6 7 9 7
dist_f30_cocaine_do_d5   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO , day 5   90351 (F) 6 12 6 6 185 6 6 9 7
(M) 6 12 7 5 190 6 7 9 7
dist_f30_cocaine_do_d7   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO , day 7   90357 (F) 6 12 5 6 186 6 6 9 7
(M) 6 12 7 5 193 6 7 9 7
dist_f30_cocaine_do_d9   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO , day 9   90363 (F) 6 12 5 6 174 6 6 9 7
(M) 6 12 7 5 180 6 7 9 7
dist_f30_cocaine_do_d11   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO , day 11   90369 (F) 6 11 6 6 147 6 6 9 7
(M) 6 12 7 5 149 6 7 9 7
dist_f30_cocaine_do_d12   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO , day 12   90375 (F) 6 12 5 6 185 6 6 9 7
(M) 6 12 7 5 189 6 7 8 7
dist_f30_cocaine_do_d19   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO , day 19   90381 (F) 6 12 5 6 185 6 6 9 7
(M) 6 12 7 5 191 6 7 9 7
dist_l60_cont_in_d1   distance traveled, last 60 min (post-injection), on successive days, saline control, founders , day 1   90382 (F) 8 7 7 7 3 5 10 8 7
(M) 8 8 6 7 3 5 9 8 7
dist_l60_cont_in_d2   distance traveled, last 60 min (post-injection), on successive days, saline control, founders , day 2   90388 (F) 8 6 7 7 3 5 10 8 7
(M) 8 8 6 7 2 5 9 7 7
dist_l60_cont_in_d3   distance traveled, last 60 min (post-injection), on successive days, saline control, founders , day 3   90394 (F) 8 7 7 7 3 5 10 8 7
(M) 8 8 5 7 2 5 9 8 7
dist_l60_cont_in_d5   distance traveled, last 60 min (post-injection), on successive days, saline control, founders , day 5   90400 (F) 8 7 7 7 3 5 9 8 7
(M) 8 8 6 7 2 5 9 7 7
dist_l60_cont_in_d7   distance traveled, last 60 min (post-injection), on successive days, saline control, founders , day 7   90406 (F) 8 7 7 7 3 5 10 8 7
(M) 8 8 6 7 2 5 9 8 7
dist_l60_cont_in_d9   distance traveled, last 60 min (post-injection), on successive days, saline control, founders , day 9   90412 (F) 8 7 7 7 3 5 10 8 7
(M) 8 8 6 7 2 5 9 8 7
dist_l60_cont_in_d11   distance traveled, last 60 min (post-injection), on successive days, saline control, founders , day 11   90418 (F) 8 5 7 7 3 5 10 8 7
(M) 8 8 6 7 2 5 9 8 7
dist_l60_cont_in_d12   distance traveled, last 60 min (post-injection), on successive days, saline control, founders , day 12   90424 (F) 8 6 7 7 3 5 10 8 7
(M) 8 8 6 7 2 5 9 8 7
dist_l60_cont_in_d19   distance traveled, last 60 min (post-injection), on successive days, saline control, founders , day 19   90430 (F) 8 6 7 7 3 5 10 8 7
(M) 8 8 6 7 2 5 9 8 7
dist_l60_cont_cc_d1   distance traveled, last 60 min (post-injection), on successive days, saline control, CC , day 1   90383 (F) 8 7 7 7 4 3 3 8 3 2 1 1 2 1 3 4 4 4 4 2 5 2 3 2 4 3 3 2 3 2 2 3 3 3 2 17 2 2 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 5 10 8 7
(M) 8 8 6 7 4 3 3 9 3 2 2 1 2 2 4 4 4 1 4 4 2 5 2 3 2 4 3 3 2 3 2 1 2 3 3 3 19 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 8 7
dist_l60_cont_cc_d2   distance traveled, last 60 min (post-injection), on successive days, saline control, CC , day 2   90389 (F) 8 6 7 7 4 3 3 11 3 2 1 1 2 1 4 4 4 4 4 2 5 2 3 2 4 3 3 2 3 2 2 3 3 3 2 19 2 1 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 5 10 8 7
(M) 8 8 6 7 4 3 3 11 3 2 2 1 2 2 4 4 4 1 4 4 2 5 2 3 2 4 3 3 2 3 2 1 2 3 3 3 20 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 7 7
dist_l60_cont_cc_d3   distance traveled, last 60 min (post-injection), on successive days, saline control, CC , day 3   90395 (F) 8 7 7 7 4 3 3 11 3 2 1 1 2 1 4 4 4 4 4 2 5 2 3 2 4 3 3 2 3 2 2 3 3 3 2 19 2 2 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 5 10 8 7
(M) 8 8 5 7 4 3 3 11 3 2 2 1 2 2 4 4 4 1 4 4 2 5 2 3 2 4 3 3 2 3 2 1 2 3 3 3 20 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 8 7
dist_l60_cont_cc_d5   distance traveled, last 60 min (post-injection), on successive days, saline control, CC , day 5   90401 (F) 8 7 7 7 4 3 3 11 3 2 1 1 2 1 4 4 4 3 4 2 5 2 3 2 4 3 3 2 3 2 2 2 3 3 2 19 2 1 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 5 9 8 7
(M) 8 8 6 7 4 3 2 11 3 2 2 1 2 2 4 4 4 1 4 4 2 5 2 3 2 2 3 3 2 3 2 1 2 3 3 3 20 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 7 7
dist_l60_cont_cc_d7   distance traveled, last 60 min (post-injection), on successive days, saline control, CC , day 7   90407 (F) 8 7 7 7 4 3 3 11 3 2 1 1 2 1 4 4 4 4 4 2 5 2 3 2 4 3 3 2 3 2 2 3 3 3 2 19 2 2 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 5 10 8 7
(M) 8 8 6 7 4 3 3 11 3 2 2 1 2 2 4 4 4 1 4 4 2 5 2 3 2 4 3 3 2 3 2 1 2 3 3 3 20 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 8 7
dist_l60_cont_cc_d9   distance traveled, last 60 min (post-injection), on successive days, saline control, CC , day 9   90413 (F) 8 7 7 7 4 3 3 11 3 2 1 1 2 1 4 4 4 4 4 2 5 2 3 2 4 2 3 2 3 2 2 3 3 3 2 19 2 1 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 5 10 8 7
(M) 8 8 6 7 4 3 3 10 3 2 2 1 2 2 4 4 4 1 4 4 2 5 2 3 2 4 3 2 2 3 2 1 2 3 3 3 18 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 8 7
dist_l60_cont_cc_d11   distance traveled, last 60 min (post-injection), on successive days, saline control, CC , day 11   90419 (F) 8 5 7 7 4 3 3 7 3 1 1 1 2 1 3 4 4 4 3 2 5 2 3 2 4 3 2 2 3 2 2 3 3 3 2 16 2 2 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 5 10 8 7
(M) 8 8 6 7 4 3 3 9 3 2 2 1 2 2 4 4 4 1 4 3 2 5 2 3 2 4 3 1 2 3 2 1 2 3 3 3 15 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 8 7
dist_l60_cont_cc_d12   distance traveled, last 60 min (post-injection), on successive days, saline control, CC , day 12   90425 (F) 8 6 7 7 4 3 3 11 3 2 1 1 2 1 4 4 4 4 4 2 5 2 3 2 4 3 3 2 3 2 2 3 3 3 2 19 2 2 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 5 10 8 7
(M) 8 8 6 7 4 3 3 11 3 2 2 1 2 2 4 4 4 1 4 4 2 5 2 3 2 3 3 2 2 3 2 1 2 3 3 3 19 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 8 7
dist_l60_cont_cc_d19   distance traveled, last 60 min (post-injection), on successive days, saline control, CC , day 19   90431 (F) 8 6 7 7 4 3 3 11 3 2 1 1 2 1 4 4 4 4 4 2 5 2 3 2 4 3 3 2 3 2 2 3 3 3 2 19 2 2 1 3 2 3 1 2 1 2 1 1 2 1 2 1 2 5 10 8 7
(M) 8 8 6 7 4 3 3 11 3 2 2 1 2 2 4 4 4 1 4 4 2 5 2 3 2 3 3 2 2 3 2 1 2 3 3 3 19 2 1 1 2 2 3 1 2 2 2 1 2 2 2 1 2 5 9 8 7
dist_l60_cont_do_d1   distance traveled, last 60 min (post-injection), on successive days, saline control, DO , day 1   90384 (F) 8 7 7 7 176 5 10 8 7
(M) 8 8 6 7 177 5 9 8 7
dist_l60_cont_do_d2   distance traveled, last 60 min (post-injection), on successive days, saline control, DO , day 2   90390 (F) 8 6 7 7 182 5 10 8 7
(M) 8 8 6 7 183 5 9 7 7
dist_l60_cont_do_d3   distance traveled, last 60 min (post-injection), on successive days, saline control, DO , day 3   90396 (F) 8 7 7 7 181 5 10 8 7
(M) 8 8 5 7 184 5 9 8 7
dist_l60_cont_do_d5   distance traveled, last 60 min (post-injection), on successive days, saline control, DO , day 5   90402 (F) 8 7 7 7 181 5 9 8 7
(M) 8 8 6 7 182 5 9 7 7
dist_l60_cont_do_d7   distance traveled, last 60 min (post-injection), on successive days, saline control, DO , day 7   90408 (F) 8 7 7 7 182 5 10 8 7
(M) 8 8 6 7 183 5 9 8 7
dist_l60_cont_do_d9   distance traveled, last 60 min (post-injection), on successive days, saline control, DO , day 9   90414 (F) 8 7 7 7 170 5 10 8 7
(M) 8 8 6 7 170 5 9 8 7
dist_l60_cont_do_d11   distance traveled, last 60 min (post-injection), on successive days, saline control, DO , day 11   90420 (F) 8 5 7 7 142 5 10 8 7
(M) 8 8 6 7 147 5 9 8 7
dist_l60_cont_do_d12   distance traveled, last 60 min (post-injection), on successive days, saline control, DO , day 12   90426 (F) 8 6 7 7 179 5 10 8 7
(M) 8 8 6 7 182 5 9 8 7
dist_l60_cont_do_d19   distance traveled, last 60 min (post-injection), on successive days, saline control, DO , day 19   90432 (F) 8 6 7 7 181 5 10 8 7
(M) 8 8 6 7 182 5 9 8 7
dist_l60_cocaine_in_d1   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders , day 1 (saline)   90385 (F) 6 12 6 1 6 3 6 6 9 7
(M) 6 12 7 1 5 4 6 7 9 7
dist_l60_cocaine_in_d2   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders , day 2 (saline)   90391 (F) 6 12 6 1 6 3 6 6 9 7
(M) 6 12 6 1 5 4 6 7 9 7
dist_l60_cocaine_in_d3   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders , day 3   90397 (F) 6 12 5 1 6 2 6 6 9 7
(M) 6 12 7 1 5 4 6 7 9 7
dist_l60_cocaine_in_d5   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders , day 5   90403 (F) 6 12 6 1 6 3 6 6 9 7
(M) 6 12 7 1 5 4 6 7 9 7
dist_l60_cocaine_in_d7   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders , day 7   90409 (F) 6 12 5 1 6 3 6 6 9 7
(M) 6 12 7 1 5 4 6 7 9 7
dist_l60_cocaine_in_d9   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders , day 9   90415 (F) 6 12 5 1 6 3 6 6 9 7
(M) 6 12 7 1 5 4 6 7 9 7
dist_l60_cocaine_in_d11   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders , day 11   90421 (F) 6 11 6 1 6 3 6 5 9 7
(M) 6 12 7 1 5 4 6 7 9 7
dist_l60_cocaine_in_d12   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders , day 12 (saline)   90427 (F) 6 12 5 1 6 3 6 6 9 7
(M) 6 12 7 1 5 4 6 7 8 7
dist_l60_cocaine_in_d19   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders , day 19   90433 (F) 6 12 5 1 6 3 6 6 9 7
(M) 6 12 7 1 5 4 6 7 9 7
dist_l60_cocaine_cc_d1   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, CC , day 1 (saline)   90386 (F) 6 12 6 6 4 3 3 17 2 2 2 3 2 2 4 4 5 2 4 4 2 4 2 3 2 4 3 3 2 3 3 2 3 3 3 3 18 2 2 2 2 2 3 1 3 1 2 2 2 2 2 2 2 2 6 6 9 7
(M) 6 12 7 5 4 3 3 17 2 2 2 3 1 2 4 4 3 1 4 4 2 5 2 3 2 4 3 3 2 3 3 3 3 3 3 2 19 2 2 2 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 9 7
dist_l60_cocaine_cc_d2   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, CC , day 2 (saline)   90392 (F) 6 12 6 6 4 3 3 19 2 2 2 3 2 2 4 4 5 2 4 4 2 4 2 3 2 4 3 3 2 3 3 2 3 3 3 3 20 2 2 2 2 2 3 1 3 1 2 2 2 2 2 2 2 2 6 6 9 7
(M) 6 12 6 5 4 3 3 20 2 2 2 3 2 2 4 4 3 1 4 4 2 5 2 3 2 4 3 3 2 3 3 3 3 3 3 2 20 2 2 2 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 9 7
dist_l60_cocaine_cc_d3   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, CC , day 3   90398 (F) 6 12 5 6 4 3 3 18 2 2 2 3 2 2 4 4 5 2 4 4 2 4 2 3 2 4 3 3 2 3 3 2 3 3 3 3 18 2 2 2 2 2 3 1 3 1 2 2 2 2 2 2 2 2 6 6 9 7
(M) 6 12 7 5 4 3 3 19 2 2 2 3 2 2 4 4 3 1 4 4 2 5 2 3 2 4 3 3 2 3 3 3 3 3 3 2 17 2 2 2 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 9 7
dist_l60_cocaine_cc_d5   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, CC , day 5   90404 (F) 6 12 6 6 4 3 2 18 2 2 2 3 2 2 4 2 5 2 4 4 2 4 2 3 2 4 3 2 2 3 3 2 3 3 3 3 20 2 2 2 2 2 3 1 2 1 2 2 2 2 2 2 2 2 6 6 9 7
(M) 6 12 7 5 4 3 3 20 2 2 2 3 2 2 4 3 3 1 3 4 2 5 2 3 2 4 3 2 2 3 3 3 3 3 3 2 20 2 2 2 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 9 7
dist_l60_cocaine_cc_d7   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, CC , day 7   90410 (F) 6 12 5 6 3 3 3 19 2 2 2 3 2 2 4 4 5 2 4 3 2 4 2 3 2 4 3 3 2 3 3 2 3 3 3 3 20 2 2 2 2 2 3 1 2 1 2 2 2 2 2 2 2 2 6 6 9 7
(M) 6 12 7 5 4 3 3 20 2 2 2 3 2 2 4 4 3 1 4 4 2 5 2 3 2 4 3 3 2 3 3 3 3 3 3 2 20 2 2 2 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 9 7
dist_l60_cocaine_cc_d9   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, CC , day 9   90416 (F) 6 12 5 6 4 3 3 19 2 2 2 3 2 2 4 4 5 2 4 4 2 4 2 3 2 4 3 3 2 3 3 2 3 3 3 3 20 2 2 2 2 2 3 1 2 1 2 2 2 2 2 2 2 2 6 6 9 7
(M) 6 12 7 5 4 3 3 20 2 2 2 3 2 2 4 4 3 1 4 4 2 5 2 3 2 4 3 3 2 3 3 3 3 3 3 2 20 2 2 2 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 9 7
dist_l60_cocaine_cc_d11   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, CC , day 11   90422 (F) 6 11 6 6 4 3 3 17 2 1 2 3 2 2 4 4 5 2 4 3 2 4 2 3 2 4 3 2 2 3 3 2 3 3 3 3 15 2 2 1 2 2 3 1 2 1 2 2 2 2 2 2 2 2 6 5 9 7
(M) 6 12 7 5 4 3 3 16 2 1 2 3 2 1 4 4 3 1 4 3 2 5 2 3 2 4 3 2 2 3 3 3 3 3 2 2 19 2 2 1 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 9 7
dist_l60_cocaine_cc_d12   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, CC , day 12 (saline)   90428 (F) 6 12 5 6 4 3 3 19 2 2 2 3 2 2 4 4 5 2 4 4 2 4 2 3 2 4 3 3 2 3 3 2 3 3 3 3 20 2 2 2 2 2 3 1 2 1 2 2 2 2 2 2 2 2 6 6 9 7
(M) 6 12 7 5 4 3 3 20 2 2 2 3 2 2 4 4 3 1 4 4 2 5 2 3 2 4 3 3 2 3 3 3 3 3 3 2 20 2 2 2 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 8 7
dist_l60_cocaine_cc_d19   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, CC , day 19   90434 (F) 6 12 5 6 4 3 3 19 2 2 2 3 2 2 4 4 5 2 4 4 2 4 2 3 2 4 3 2 2 3 3 2 3 3 3 3 20 2 2 2 2 2 3 1 2 1 2 2 2 2 2 2 2 2 6 6 9 7
(M) 6 12 7 5 4 3 3 20 2 2 2 3 2 2 4 4 3 1 4 4 2 5 2 3 2 4 3 3 2 3 3 3 3 3 3 2 20 2 2 2 3 2 3 1 2 2 2 2 2 2 2 2 2 6 7 9 7
dist_l60_cocaine_do_d1   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, DO , day 1 (saline)   90387 (F) 6 12 6 6 183 6 6 9 7
(M) 6 12 7 5 187 6 7 9 7
dist_l60_cocaine_do_d2   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, DO , day 2 (saline)   90393 (F) 6 12 6 6 186 6 6 9 7
(M) 6 12 6 5 192 6 7 9 7
dist_l60_cocaine_do_d3   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, DO , day 3   90399 (F) 6 12 5 6 187 6 6 9 7
(M) 6 12 7 5 193 6 7 9 7
dist_l60_cocaine_do_d5   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, DO , day 5   90405 (F) 6 12 6 6 185 6 6 9 7
(M) 6 12 7 5 190 6 7 9 7
dist_l60_cocaine_do_d7   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, DO , day 7   90411 (F) 6 12 5 6 186 6 6 9 7
(M) 6 12 7 5 193 6 7 9 7
dist_l60_cocaine_do_d9   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, DO , day 9   90417 (F) 6 12 5 6 174 6 6 9 7
(M) 6 12 7 5 180 6 7 9 7
dist_l60_cocaine_do_d11   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, DO , day 11   90423 (F) 6 11 6 6 146 6 5 9 7
(M) 6 12 7 5 147 6 7 9 7
dist_l60_cocaine_do_d12   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, DO , day 12 (saline)   90429 (F) 6 12 5 6 185 6 6 9 7
(M) 6 12 7 5 189 6 7 8 7
dist_l60_cocaine_do_d19   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, DO , day 19   90435 (F) 6 12 5 6 185 6 6 9 7
(M) 6 12 7 5 191 6 7 9 7
acquisition_in   number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), founders   110188 (F) 12 13 8 13 13 11 5
(M) 9 13 4 9 11 11 8
acquisition_cc   number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), CC   110390 (F) 12 13 8 4 3 1 12 4 2 2 1 2 4 2 3 1 2 3 2 5 1 2 1 2 5 3 5 2 3 1 3 3 2 1 1 2 2 4 2 1 1 2 2 2 2 13 13 11 5
(M) 9 13 4 4 2 3 21 3 1 2 2 2 5 1 3 1 2 2 5 3 3 1 1 3 5 6 1 2 4 2 2 2 2 1 2 3 2 4 1 2 1 2 2 3 9 11 11 8
acquisition_do   number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), DO   110261 (F) 12 13 8 321 13 13 11 5
(M) 9 13 4 302 9 11 11 8
infusions_in_1p0   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, founders , 1.0 mg/kg   110189 (F) 12 15 24 10 15 14 18 18
(M) 12 11 21 8 10 11 14 17
infusions_in_1p8   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, founders , 1.8 mg/kg   110190 (F) 7 11 1 10 11 9 1
(M) 7 11 2 7 10 8 6
infusions_in_0p56   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, founders , 0.56 mg/kg   110191 (F) 9 11 6 12 13 10 2
(M) 8 11 4 9 11 11 7
infusions_in_0p32   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, founders , 0.32 mg/kg   110192 (F) 11 13 5 13 13 11 3
(M) 8 13 4 9 11 10 7
infusions_in_0p1   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, founders , 0.1 mg/kg   110193 (F) 11 13 3 13 12 10 3
(M) 7 13 3 9 11 10 6
infusions_in_0p18   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, founders , 0.18 mg/kg   110194 (F) 9 11 4 12 12 10 1
(M) 7 11 3 9 11 10 6
infusions_in_0p056   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, founders , 0.056 mg/kg   110195 (F) 9 11 2 10 12 9 1
(M) 7 11 3 8 11 10 6
infusions_in_0p032   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, founders , 0.032 mg/kg   110196 (F) 9 13 1 11 11 10 3
(M) 7 13 3 7 10 10 6
infusions_in_1p0_2nd   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, founders , 1.0 (2nd) mg/kg   110197 (F) 2 2 1 1 2
(M) 2
infusions_cc_1p0   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, CC , 1.0 mg/kg   110391 (F) 12 15 24 10 4 3 4 12 5 3 2 3 4 1 6 7 5 2 3 4 3 5 1 4 3 2 6 7 6 2 2 3 1 4 3 4 2 14 3 1 2 2 4 2 2 5 2 3 3 2 4 2 15 14 18 18
(M) 12 11 21 8 4 4 4 25 5 4 3 2 3 2 6 7 3 2 5 5 6 3 1 3 3 3 5 5 6 1 2 4 2 2 3 4 2 26 2 3 3 2 4 2 2 3 1 2 3 2 5 10 11 14 17
infusions_cc_1p8   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, CC , 1.8 mg/kg   110392 (F) 7 11 1 8 5 3 10 11 9 1
(M) 7 11 2 8 3 1 7 10 8 6
infusions_cc_0p56   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, CC , 0.56 mg/kg   110393 (F) 9 11 6 9 5 5 12 13 10 2
(M) 8 11 4 9 3 1 9 11 11 7
infusions_cc_0p32   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, CC , 0.32 mg/kg   110394 (F) 11 13 5 3 3 2 11 4 2 2 2 3 5 2 3 2 2 3 3 5 1 4 2 2 5 4 5 1 2 3 1 3 3 1 2 5 2 1 2 2 4 2 4 1 1 2 2 2 2 13 13 11 3
(M) 8 13 4 4 2 4 22 3 2 3 2 3 5 3 3 1 2 4 5 3 3 2 2 3 5 6 1 2 4 2 2 2 1 2 12 2 2 3 2 3 1 2 2 1 3 2 3 9 11 10 7
infusions_cc_0p1   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, CC , 0.1 mg/kg   110395 (F) 11 13 3 3 3 2 10 4 2 2 2 3 5 1 3 2 2 3 3 5 1 4 2 2 5 4 5 1 2 3 1 3 3 1 2 3 2 1 2 2 4 2 3 1 1 2 2 2 2 13 12 10 3
(M) 7 13 3 4 2 4 22 3 2 3 2 3 5 3 3 1 2 4 5 3 3 2 2 3 5 5 1 2 4 2 2 2 1 2 12 1 2 3 2 3 1 2 2 1 3 2 3 9 11 10 6
infusions_cc_0p18   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, CC , 0.18 mg/kg   110396 (F) 9 11 4 9 5 3 12 12 10 1
(M) 7 11 3 9 3 1 9 11 10 6
infusions_cc_0p056   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, CC , 0.056 mg/kg   110397 (F) 9 11 2 8 5 3 10 12 9 1
(M) 7 11 3 8 3 1 8 11 10 6
infusions_cc_0p032   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, CC , 0.032 mg/kg   110398 (F) 9 13 1 3 3 2 10 4 2 2 2 3 5 1 3 2 2 3 3 5 1 4 2 2 5 4 5 1 2 3 1 3 3 1 2 3 2 1 2 2 4 2 3 1 1 2 2 2 2 11 11 10 3
(M) 7 13 3 4 2 4 20 3 2 3 2 3 5 3 3 1 2 4 5 3 3 2 2 3 5 5 1 2 4 2 2 2 1 2 12 1 2 3 2 3 1 2 2 1 3 2 3 7 10 10 6
infusions_cc_1p0_2nd   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, CC , 1.0 (2nd) mg/kg   110399 (F) 2 2 3 3 2 2 4 2 2 2 3 5 1 3 2 2 3 3 5 1 4 2 2 4 4 1 2 3 1 3 3 1 2 2 2 2 4 2 3 1 1 2 2 2 2 1 1 2
(M) 2 4 2 4 14 3 2 3 2 3 4 3 3 1 2 4 5 3 3 2 1 5 5 1 2 4 2 2 2 1 2 11 1 2 3 2 3 1 2 2 1 3 2 1
infusions_do_1p0   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, DO , 1.0 mg/kg   110262 (F) 12 15 24 10 546 15 14 18 18
(M) 12 11 21 8 537 10 11 14 17
infusions_do_1p8   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, DO , 1.8 mg/kg   110263 (F) 7 11 1 15 10 11 9 1
(M) 7 11 2 24 7 10 8 6
infusions_do_0p56   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, DO , 0.56 mg/kg   110264 (F) 9 11 6 23 12 13 10 2
(M) 8 11 4 30 9 11 11 7
infusions_do_0p32   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, DO , 0.32 mg/kg   110265 (F) 11 13 5 325 13 13 11 3
(M) 8 13 4 307 9 11 10 7
infusions_do_0p1   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, DO , 0.1 mg/kg   110266 (F) 11 13 3 320 13 12 10 3
(M) 7 13 3 302 9 11 10 6
infusions_do_0p18   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, DO , 0.18 mg/kg   110267 (F) 9 11 4 21 12 12 10 1
(M) 7 11 3 27 9 11 10 6
infusions_do_0p056   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, DO , 0.056 mg/kg   110268 (F) 9 11 2 19 10 12 9 1
(M) 7 11 3 26 8 11 10 6
infusions_do_0p032   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, DO , 0.032 mg/kg   110269 (F) 9 13 1 311 11 11 10 3
(M) 7 13 3 295 7 10 10 6
infusions_do_1p0_2nd   dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, DO , 1.0 (2nd) mg/kg   110270 (F) 2 2 289 1 1 2
(M) 2 264
extinction_active_in_s1   extinction, active lever presses (intravenous self administration), founders , session 1   110198 (F) 9 12 1 10 10 6 2
(M) 7 12 2 6 9 7 5
extinction_active_in_s2   extinction, active lever presses (intravenous self administration), founders , session 2   110199 (F) 9 11 1 11 10 5 2
(M) 6 12 2 7 9 7 5
extinction_active_in_s3   extinction, active lever presses (intravenous self administration), founders , session 3   110200 (F) 8 11 1 11 10 6 2
(M) 7 13 2 6 10 7 5
extinction_active_in_s4   extinction, active lever presses (intravenous self administration), founders , session 4   110201 (F) 6 12 1 11 10 7 3
(M) 7 11 2 5 10 7 5
extinction_active_in_s5   extinction, active lever presses (intravenous self administration), founders , session 5   110202 (F) 7 11 1 10 10 5 3
(M) 7 11 2 5 10 7 5
extinction_active_in_s6   extinction, active lever presses (intravenous self administration), founders , session 6   110203 (F) 7 10 1 10 10 5 3
(M) 7 11 2 6 10 7 5
extinction_active_in_s7   extinction, active lever presses (intravenous self administration), founders , session 7   110204 (F) 7 11 1 9 10 6 3
(M) 7 11 2 6 10 6 5
extinction_active_in_s8   extinction, active lever presses (intravenous self administration), founders , session 8   110205 (F) 1 1 2
(M)
extinction_active_in_s9   extinction, active lever presses (intravenous self administration), founders , session 9   110206 (F) 1 2
(M)
extinction_active_cc_s1   extinction, active lever presses (intravenous self administration), CC , session 1   110400 (F) 9 12 1 3 3 2 9 4 2 1 2 3 3 1 3 2 2 3 3 4 1 3 2 2 5 4 4 1 1 2 1 3 3 1 2 3 1 2 2 4 2 3 2 1 2 1 10 10 6 2
(M) 7 12 2 4 2 4 19 2 2 3 2 3 3 3 3 1 2 4 5 3 3 2 1 3 4 4 1 2 4 1 2 2 1 1 12 1 1 3 2 3 1 2 2 1 3 2 1 6 9 7 5
extinction_active_cc_s2   extinction, active lever presses (intravenous self administration), CC , session 2   110401 (F) 9 11 1 3 3 2 9 4 2 1 2 3 3 1 3 1 2 3 3 5 1 3 2 2 5 3 4 1 2 3 1 2 3 1 2 3 1 1 2 3 2 2 2 2 2 2 11 10 5 2
(M) 6 12 2 3 2 4 19 2 2 3 2 3 3 3 3 1 2 4 5 2 3 2 1 3 4 3 1 2 4 1 2 2 1 2 12 1 2 3 2 3 1 2 2 1 3 2 1 7 9 7 5
extinction_active_cc_s3   extinction, active lever presses (intravenous self administration), CC , session 3   110402 (F) 8 11 1 3 3 2 9 4 1 2 2 3 3 1 3 1 2 3 3 5 1 3 2 2 5 3 4 1 2 3 1 2 3 1 1 2 1 2 2 3 2 2 1 1 2 2 2 2 11 10 6 2
(M) 7 13 2 4 1 3 19 2 2 3 2 3 2 3 3 1 2 4 5 2 3 1 3 4 5 1 2 4 1 2 2 1 2 12 1 2 3 2 3 1 2 2 1 3 2 1 6 10 7 5
extinction_active_cc_s4   extinction, active lever presses (intravenous self administration), CC , session 4   110403 (F) 6 12 1 3 3 2 8 1 2 2 3 1 2 1 1 3 5 2 1 5 1 3 2 1 1 2 3 1 1 2 1 2 1 4 2 1 2 2 1 11 10 7 3
(M) 7 11 2 4 2 3 18 2 1 2 2 2 3 2 3 2 5 2 3 3 2 5 1 2 3 1 2 1 1 2 1 1 3 2 1 1 2 1 1 5 10 7 5
extinction_active_cc_s5   extinction, active lever presses (intravenous self administration), CC , session 5   110404 (F) 7 11 1 3 3 1 8 1 1 1 3 1 1 1 3 4 2 1 5 1 2 2 1 1 2 1 2 1 1 2 4 1 2 2 1 10 10 5 3
(M) 7 11 2 4 3 17 1 1 2 2 1 3 1 3 1 4 2 3 1 3 1 2 1 3 1 2 1 1 1 1 1 3 1 1 2 1 5 10 7 5
extinction_active_cc_s6   extinction, active lever presses (intravenous self administration), CC , session 6   110405 (F) 7 10 1 3 3 1 8 1 1 1 1 2 1 2 1 3 4 1 1 1 5 1 3 2 1 1 2 2 1 1 2 1 1 2 1 10 10 5 3
(M) 7 11 2 4 3 16 1 1 2 2 1 2 3 1 4 2 2 1 3 1 1 2 1 2 1 1 2 1 1 2 1 1 1 6 10 7 5
extinction_active_cc_s7   extinction, active lever presses (intravenous self administration), CC , session 7   110406 (F) 7 11 1 3 1 8 1 1 1 1 2 1 2 1 3 4 1 1 1 5 1 3 2 1 3 2 1 1 2 1 2 1 9 10 6 3
(M) 7 11 2 2 1 14 1 2 2 1 1 2 5 2 1 1 3 1 2 1 1 1 2 1 1 2 1 1 1 6 10 6 5
extinction_active_cc_s8   extinction, active lever presses (intravenous self administration), CC , session 8   110407 (F) 1 1 3 1 1 1 1 1 2 2 3 3 1 1 1 1 3 1 3 1 1 3 1 2 1 1 2
(M) 2 1 7 1 2 2 2 1 2 4 2 1 1 1 1 1 1 1 1 1 1 2 1 1 1
extinction_active_cc_s9   extinction, active lever presses (intravenous self administration), CC , session 9   110408 (F) 1 1 3 1 1 1 1 1 1 2 2 2 3 1 1 1 1 3 1 3 1 1 3 1 1 2 2
(M) 2 5 1 2 1 2 1 2 4 2 1 1 1 1 1 1 1 1 2 1 1
extinction_active_do_s1   extinction, active lever presses (intravenous self administration), DO , session 1   110271 (F) 9 12 1 274 10 10 6 2
(M) 7 12 2 259 6 9 7 5
extinction_active_do_s2   extinction, active lever presses (intravenous self administration), DO , session 2   110272 (F) 9 11 1 273 11 10 5 2
(M) 6 12 2 258 7 9 7 5
extinction_active_do_s3   extinction, active lever presses (intravenous self administration), DO , session 3   110273 (F) 8 11 1 273 11 10 6 2
(M) 7 13 2 265 6 10 7 5
extinction_active_do_s4   extinction, active lever presses (intravenous self administration), DO , session 4   110274 (F) 6 12 1 236 11 10 7 3
(M) 7 11 2 208 5 10 7 5
extinction_active_do_s5   extinction, active lever presses (intravenous self administration), DO , session 5   110275 (F) 7 11 1 198 10 10 5 3
(M) 7 11 2 165 5 10 7 5
extinction_active_do_s6   extinction, active lever presses (intravenous self administration), DO , session 6   110276 (F) 7 10 1 164 10 10 5 3
(M) 7 11 2 140 6 10 7 5
extinction_active_do_s7   extinction, active lever presses (intravenous self administration), DO , session 7   110277 (F) 7 11 1 146 9 10 6 3
(M) 7 11 2 127 6 10 6 5
extinction_active_do_s8   extinction, active lever presses (intravenous self administration), DO , session 8   110278 (F) 1 120 1 2
(M) 97
extinction_active_do_s9   extinction, active lever presses (intravenous self administration), DO , session 9   110279 (F) 1 102 2
(M) 88
extinction_inactive_in_s1   extinction, inactive lever presses (intravenous self administration), founders , session 1   110207 (F) 9 12 1 10 10 6 2
(M) 7 12 2 6 9 7 5
extinction_inactive_in_s2   extinction, inactive lever presses (intravenous self administration), founders , session 2   110208 (F) 9 11 1 11 10 5 2
(M) 6 12 2 7 9 7 5
extinction_inactive_in_s3   extinction, inactive lever presses (intravenous self administration), founders , session 3   110209 (F) 8 11 1 11 10 6 2
(M) 7 13 2 6 10 7 5
extinction_inactive_in_s4   extinction, inactive lever presses (intravenous self administration), founders , session 4   110210 (F) 6 12 1 11 10 7 3
(M) 7 11 2 5 10 7 5
extinction_inactive_in_s5   extinction, inactive lever presses (intravenous self administration), founders , session 5   110211 (F) 7 11 1 10 10 5 3
(M) 7 11 2 5 10 7 5
extinction_inactive_in_s6   extinction, inactive lever presses (intravenous self administration), founders , session 6   110212 (F) 7 10 1 10 10 5 3
(M) 7 11 2 6 10 7 5
extinction_inactive_in_s7   extinction, inactive lever presses (intravenous self administration), founders , session 7   110213 (F) 7 11 1 9 10 6 3
(M) 7 11 2 6 10 6 5
extinction_inactive_in_s8   extinction, inactive lever presses (intravenous self administration), founders , session 8   110214 (F) 1 1 2
(M)
extinction_inactive_in_s9   extinction, inactive lever presses (intravenous self administration), founders , session 9   110215 (F) 1 2
(M)
extinction_inactive_cc_s1   extinction, inactive lever presses (intravenous self administration), CC , session 1   110409 (F) 9 12 1 3 3 2 9 4 2 1 2 3 3 1 3 2 2 3 3 4 1 3 2 2 5 4 4 1 1 2 1 3 3 1 2 3 1 2 2 4 2 3 2 1 2 1 10 10 6 2
(M) 7 12 2 4 2 4 19 2 2 3 2 3 3 3 3 1 2 4 5 3 3 2 1 3 4 4 1 2 4 1 2 2 1 1 12 1 1 3 2 3 1 2 2 1 3 2 1 6 9 7 5
extinction_inactive_cc_s2   extinction, inactive lever presses (intravenous self administration), CC , session 2   110410 (F) 9 11 1 3 3 2 9 4 2 1 2 3 3 1 3 1 2 3 3 5 1 3 2 2 5 3 4 1 2 3 1 2 3 1 2 3 1 1 2 3 2 2 2 2 2 2 11 10 5 2
(M) 6 12 2 3 2 4 19 2 2 3 2 3 3 3 3 1 2 4 5 2 3 2 1 3 4 3 1 2 4 1 2 2 1 2 12 1 2 3 2 3 1 2 2 1 3 2 1 7 9 7 5
extinction_inactive_cc_s3   extinction, inactive lever presses (intravenous self administration), CC , session 3   110411 (F) 8 11 1 3 3 2 9 4 1 2 2 3 3 1 3 1 2 3 3 5 1 3 2 2 5 3 4 1 2 3 1 2 3 1 1 2 1 2 2 3 2 2 1 1 2 2 2 2 11 10 6 2
(M) 7 13 2 4 1 3 19 2 2 3 2 3 2 3 3 1 2 4 5 2 3 1 3 4 5 1 2 4 1 2 2 1 2 12 1 2 3 2 3 1 2 2 1 3 2 1 6 10 7 5
extinction_inactive_cc_s4   extinction, inactive lever presses (intravenous self administration), CC , session 4   110412 (F) 6 12 1 3 3 2 8 1 2 2 3 1 2 1 1 3 5 2 1 5 1 3 2 1 1 2 3 1 1 2 1 2 1 4 2 1 2 2 1 11 10 7 3
(M) 7 11 2 4 2 3 18 2 1 2 2 2 3 2 3 2 5 2 3 3 2 5 1 2 3 1 2 1 1 2 1 1 3 2 1 1 2 1 1 5 10 7 5
extinction_inactive_cc_s5   extinction, inactive lever presses (intravenous self administration), CC , session 5   110413 (F) 7 11 1 3 3 1 8 1 1 1 3 1 1 1 3 4 2 1 5 1 2 2 1 1 2 1 2 1 1 2 4 1 2 2 1 10 10 5 3
(M) 7 11 2 4 3 17 1 1 2 2 1 3 1 3 1 4 2 3 1 3 1 2 1 3 1 2 1 1 1 1 1 3 1 1 2 1 5 10 7 5
extinction_inactive_cc_s6   extinction, inactive lever presses (intravenous self administration), CC , session 6   110414 (F) 7 10 1 3 3 1 8 1 1 1 1 2 1 2 1 3 4 1 1 1 5 1 3 2 1 1 2 2 1 1 2 1 1 2 1 10 10 5 3
(M) 7 11 2 4 3 16 1 1 2 2 1 2 3 1 4 2 2 1 3 1 1 2 1 2 1 1 2 1 1 2 1 1 1 6 10 7 5
extinction_inactive_cc_s7   extinction, inactive lever presses (intravenous self administration), CC , session 7   110415 (F) 7 11 1 3 1 8 1 1 1 1 2 1 2 1 3 4 1 1 1 5 1 3 2 1 3 2 1 1 2 1 2 1 9 10 6 3
(M) 7 11 2 2 1 14 1 2 2 1 1 2 5 2 1 1 3 1 2 1 1 1 2 1 1 2 1 1 1 6 10 6 5
extinction_inactive_cc_s8   extinction, inactive lever presses (intravenous self administration), CC , session 8   110416 (F) 1 1 3 1 1 1 1 1 2 2 3 3 1 1 1 1 3 1 3 1 1 3 1 2 1 1 2
(M) 2 1 7 1 2 2 2 1 2 4 2 1 1 1 1 1 1 1 1 1 1 2 1 1 1
extinction_inactive_cc_s9   extinction, inactive lever presses (intravenous self administration), CC , session 9   110417 (F) 1 1 3 1 1 1 1 1 1 2 2 2 3 1 1 1 1 3 1 3 1 1 3 1 1 2 2
(M) 2 5 1 2 1 2 1 2 4 2 1 1 1 1 1 1 1 1 2 1 1
extinction_inactive_do_s1   extinction, inactive lever presses (intravenous self administration), DO , session 1   110280 (F) 9 12 1 274 10 10 6 2
(M) 7 12 2 259 6 9 7 5
extinction_inactive_do_s2   extinction, inactive lever presses (intravenous self administration), DO , session 2   110281 (F) 9 11 1 273 11 10 5 2
(M) 6 12 2 258 7 9 7 5
extinction_inactive_do_s3   extinction, inactive lever presses (intravenous self administration), DO , session 3   110282 (F) 8 11 1 273 11 10 6 2
(M) 7 13 2 265 6 10 7 5
extinction_inactive_do_s4   extinction, inactive lever presses (intravenous self administration), DO , session 4   110283 (F) 6 12 1 236 11 10 7 3
(M) 7 11 2 208 5 10 7 5
extinction_inactive_do_s5   extinction, inactive lever presses (intravenous self administration), DO , session 5   110284 (F) 7 11 1 198 10 10 5 3
(M) 7 11 2 165 5 10 7 5
extinction_inactive_do_s6   extinction, inactive lever presses (intravenous self administration), DO , session 6   110285 (F) 7 10 1 164 10 10 5 3
(M) 7 11 2 140 6 10 7 5
extinction_inactive_do_s7   extinction, inactive lever presses (intravenous self administration), DO , session 7   110286 (F) 7 11 1 146 9 10 6 3
(M) 7 11 2 127 6 10 6 5
extinction_inactive_do_s8   extinction, inactive lever presses (intravenous self administration), DO , session 8   110287 (F) 1 120 1 2
(M) 97
extinction_inactive_do_s9   extinction, inactive lever presses (intravenous self administration), DO , session 9   110288 (F) 1 102 2
(M) 88
reinstatement_active_in_s1   reinstatement, active lever presses (intravenous self administration), founders , session 1   110216 (F) 9 12 1 11 10 7 3
(M) 7 13 2 6 10 6 5
reinstatement_active_in_s2   reinstatement, active lever presses (intravenous self administration), founders , session 2   110217 (F) 9 12 1 11 10 7 3
(M) 7 13 2 6 10 6 5
reinstatement_active_cc_s1   reinstatement, active lever presses (intravenous self administration), CC , session 1   110418 (F) 9 12 1 3 3 2 9 4 2 2 2 3 3 1 3 2 2 3 3 5 1 3 2 2 5 4 4 1 2 3 1 3 3 1 2 2 2 2 2 4 2 2 1 1 2 2 2 2 11 10 7 3
(M) 7 13 2 4 2 4 19 2 2 3 2 3 3 3 3 1 2 4 5 3 3 2 1 3 4 5 1 2 4 2 2 2 1 2 12 1 2 3 2 3 1 2 2 1 3 2 1 6 10 6 5
reinstatement_active_cc_s2   reinstatement, active lever presses (intravenous self administration), CC , session 2   110419 (F) 9 12 1 3 3 2 9 4 2 2 2 3 3 1 3 2 2 3 3 5 1 3 2 2 5 4 4 1 2 3 1 3 3 1 2 2 2 2 2 4 2 2 1 1 2 2 2 2 11 10 7 3
(M) 7 13 2 4 2 4 19 2 2 3 2 3 3 3 3 1 2 4 5 3 3 2 1 3 4 5 1 2 4 2 2 2 1 2 12 1 2 3 2 3 1 2 2 1 3 2 1 6 10 6 5
reinstatement_active_do_s1   reinstatement, active lever presses (intravenous self administration), DO , session 1   110289 (F) 9 12 1 295 11 10 7 3
(M) 7 13 2 281 6 10 6 5
reinstatement_active_do_s2   reinstatement, active lever presses (intravenous self administration), DO , session 2   110290 (F) 9 12 1 293 11 10 7 3
(M) 7 13 2 281 6 10 6 5
reinstatement_active_do_s3   reinstatement, active lever presses (intravenous self administration), DO , session 3   110291 (F) 2
(M)
reinstatement_inactive_in_s1   reinstatement, inactive lever presses (intravenous self administration), founders , session 1   110218 (F) 9 12 1 11 10 7 3
(M) 7 13 2 6 10 6 5
reinstatement_inactive_in_s2   reinstatement, inactive lever presses (intravenous self administration), founders , session 2   110219 (F) 9 12 1 11 10 7 3
(M) 7 13 2 6 10 6 5
reinstatement_inactive_cc_s1   reinstatement, inactive lever presses (intravenous self administration), CC , session 1   110420 (F) 9 12 1 3 3 2 9 4 2 2 2 3 3 1 3 2 2 3 3 5 1 3 2 2 5 4 4 1 2 3 1 3 3 1 2 2 2 2 2 4 2 2 1 1 2 2 2 2 11 10 7 3
(M) 7 13 2 4 2 4 19 2 2 3 2 3 3 3 3 1 2 4 5 3 3 2 1 3 4 5 1 2 4 2 2 2 1 2 12 1 2 3 2 3 1 2 2 1 3 2 1 6 10 6 5
reinstatement_inactive_cc_s2   reinstatement, inactive lever presses (intravenous self administration), CC , session 2   110421 (F) 9 12 1 3 3 2 9 4 2 2 2 3 3 1 3 2 2 3 3 5 1 3 2 2 5 4 4 1 2 3 1 3 3 1 2 2 2 2 2 4 2 2 1 1 2 2 2 2 11 10 7 3
(M) 7 13 2 4 2 4 19 2 2 3 2 3 3 3 3 1 2 4 5 3 3 2 1 3 4 5 1 2 4 2 2 2 1 2 12 1 2 3 2 3 1 2 2 1 3 2 1 6 10 6 5
reinstatement_inactive_do_s1   reinstatement, inactive lever presses (intravenous self administration), DO , session 1   110292 (F) 9 12 1 295 11 10 7 3
(M) 7 13 2 281 6 10 6 5
reinstatement_inactive_do_s2   reinstatement, inactive lever presses (intravenous self administration), DO , session 2   110293 (F) 9 12 1 293 11 10 7 3
(M) 7 13 2 281 6 10 6 5
reinstatement_inactive_do_s3   reinstatement, inactive lever presses (intravenous self administration), DO , session 3   110294 (F) 2
(M)
reinstatement_inf_in_s1   reinstatement, number of infusions (intravenous self administration), founders , session 1   110220 (F) 9 12 1 11 10 7 3
(M) 7 13 2 6 10 6 5
reinstatement_inf_in_s2   reinstatement, number of infusions (intravenous self administration), founders , session 2   110221 (F) 9 12 1 11 10 7 3
(M) 7 13 2 6 10 6 5
reinstatement_inf_cc_s1   reinstatement, number of infusions (intravenous self administration), CC , session 1   110422 (F) 9 12 1 3 3 2 9 4 2 2 2 3 3 1 3 2 2 3 3 5 1 3 2 2 5 4 4 1 2 3 1 3 3 1 2 2 2 2 2 4 2 2 1 1 2 2 2 2 11 10 7 3
(M) 7 13 2 4 2 4 19 2 2 3 2 3 3 3 3 1 2 4 5 3 3 2 1 3 4 5 1 2 4 2 2 2 1 2 12 1 2 3 2 3 1 2 2 1 3 2 1 6 10 6 5
reinstatement_inf_cc_s2   reinstatement, number of infusions (intravenous self administration), CC , session 2   110423 (F) 9 12 1 3 3 2 9 4 2 2 2 3 3 1 3 2 2 3 3 5 1 3 2 2 5 4 4 1 2 3 1 3 3 1 2 2 2 2 2 4 2 2 1 1 2 2 2 2 11 10 7 3
(M) 7 13 2 4 2 4 19 2 2 3 2 3 3 3 3 1 2 4 5 3 3 2 1 3 4 5 1 2 4 2 2 2 1 2 12 1 2 3 2 3 1 2 2 1 3 2 1 6 10 6 5
reinstatement_inf_do_s1   reinstatement, number of infusions (intravenous self administration), DO , session 1   110295 (F) 9 12 1 295 11 10 7 3
(M) 7 13 2 281 6 10 6 5
reinstatement_inf_do_s2   reinstatement, number of infusions (intravenous self administration), DO , session 2   110296 (F) 9 12 1 293 11 10 7 3
(M) 7 13 2 281 6 10 6 5
reinstatement_inf_do_s3   reinstatement, number of infusions (intravenous self administration), DO , session 3   110297 (F) 2
(M)
days_criteria_in_acq_JAX   number of days to meet criteria, (reversal learning assay), founders , acquisition   110457 (F) 3 6 14 10 8 3 9 8
(M) 4 5 11 8 11 2 8 6
days_criteria_in_rev_JAX   number of days to meet criteria, (reversal learning assay), founders , reversal   110458 (F) 3 6 14 10 8 3 9 8
(M) 4 5 11 8 11 2 8 6
days_criteria_cc_acq_JAX   number of days to meet criteria, (reversal learning assay), CC , acquisition   110487 (F) 3 6 14 10 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 3 9 8
(M) 4 5 11 8 2 4 3 2 2 2 1 2 3 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 6
days_criteria_cc_rev_JAX   number of days to meet criteria, (reversal learning assay), CC , reversal   110488 (F) 3 6 14 10 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 3 9 8
(M) 4 5 11 8 2 4 3 2 2 2 1 2 3 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 6
days_criteria_do_acq_JAX   number of days to meet criteria, (reversal learning assay), DO , acquisition   110517 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
days_criteria_do_rev_JAX   number of days to meet criteria, (reversal learning assay), DO , reversal   110518 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
trials_in_acq_JAX   total number of trials (reversal learning assay), founders , acquisition   110459 (F) 3 6 14 10 8 3 9 8
(M) 4 5 11 8 11 2 8 6
trials_in_rev_JAX   total number of trials (reversal learning assay), founders , reversal   110460 (F) 3 6 14 10 8 3 9 8
(M) 4 5 11 8 11 2 8 6
trials_cc_acq_JAX   total number of trials (reversal learning assay), CC , acquisition   110489 (F) 3 6 14 10 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 3 9 8
(M) 4 5 11 8 2 4 3 2 2 2 1 2 3 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 6
trials_cc_rev_JAX   total number of trials (reversal learning assay), CC , reversal   110490 (F) 3 6 14 10 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 3 9 8
(M) 4 5 11 8 2 4 3 2 2 2 1 2 3 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 6
trials_do_acq_JAX   total number of trials (reversal learning assay), DO , acquisition   110519 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
trials_do_rev_JAX   total number of trials (reversal learning assay), DO , reversal   110520 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
diff_trials_rev_acq_in_JAX   reversal trials minus acquisition trials (reversal learning assay), founders   113850 (F) 3 6 14 10 8 3 9 8
(M) 4 5 11 8 11 2 8 6
diff_trials_rev_acq_cc_JAX   reversal trials minus acquisition trials (reversal learning assay), CC   113851 (F) 3 6 14 10 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 3 9 8
(M) 4 5 11 8 2 4 3 2 2 2 1 2 3 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 6
diff_trials_rev_acq_do_JAX   reversal trials minus acquisition trials (reversal learning assay), DO   113853 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
correct_in_acq_JAX   total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders , acquisition   110461 (F) 3 6 14 10 8 3 9 8
(M) 4 5 11 8 11 2 8 6
correct_in_rev_JAX   total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders , reversal   110462 (F) 3 6 14 10 8 3 9 8
(M) 4 5 11 8 11 2 8 6
correct_cc_acq_JAX   total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC , acquisition   110491 (F) 3 6 14 10 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 3 9 8
(M) 4 5 11 8 2 4 3 2 2 2 1 2 3 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 6
correct_cc_rev_JAX   total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC , reversal   110492 (F) 3 6 14 10 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 3 9 8
(M) 4 5 11 8 2 4 3 2 2 2 1 2 3 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 6
correct_do_acq_JAX   total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), DO , acquisition   110521 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
correct_do_rev_JAX   total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), DO , reversal   110522 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
omit_in_acq_JAX   total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders , acquisition   110463 (F) 3 6 14 8 8 2 7 8
(M) 4 5 10 8 10 1 8 6
omit_in_rev_JAX   total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders , reversal   110464 (F) 3 6 14 10 7 3 8 8
(M) 4 5 11 8 11 2 8 5
omit_cc_acq_JAX   total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC , acquisition   110493 (F) 3 6 14 8 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 2 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 2 7 8
(M) 4 5 10 8 2 3 3 1 2 2 1 2 3 1 2 1 4 2 2 4 1 3 2 4 3 1 1 2 1 3 3 2 2 1 1 2 4 1 2 1 1 3 2 1 2 10 1 8 6
omit_cc_rev_JAX   total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC , reversal   110494 (F) 3 6 14 10 3 4 2 1 2 2 1 1 2 2 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 2 3 2 1 1 2 4 1 3 1 2 3 1 2 2 7 3 8 8
(M) 4 5 11 8 2 4 3 2 2 2 1 2 3 1 2 1 3 3 2 4 1 3 2 4 3 1 1 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 5
omit_do_acq_JAX   total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), DO , acquisition   110523 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
omit_do_rev_JAX   total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), DO , reversal   110524 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
pct_correct_in_acq_JAX   percentage of responses that are correct (reversal learning assay), founders , acquisition   110465 (F) 3 6 14 10 8 3 9 8
(M) 4 5 11 8 11 2 8 6
pct_correct_in_rev_JAX   percentage of responses that are correct (reversal learning assay), founders , reversal   110466 (F) 3 6 14 10 8 3 9 8
(M) 4 5 11 8 11 2 8 6
pct_correct_cc_acq_JAX   percentage of responses that are correct (reversal learning assay), CC , acquisition   110495 (F) 3 6 14 10 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 3 9 8
(M) 4 5 11 8 2 4 3 2 2 2 1 2 3 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 6
pct_correct_cc_rev_JAX   percentage of responses that are correct (reversal learning assay), CC , reversal   110496 (F) 3 6 14 10 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 3 9 8
(M) 4 5 11 8 2 4 3 2 2 2 1 2 3 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 6
pct_correct_do_acq_JAX   percentage of responses that are correct (reversal learning assay), DO , acquisition   110525 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
pct_correct_do_rev_JAX   percentage of responses that are correct (reversal learning assay), DO , reversal   110526 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
pct_omit_in_acq_JAX   percentage of responses considered omissions (reversal learning assay), founders , acquisition   110467 (F) 3 6 14 8 8 2 7 8
(M) 4 5 10 8 10 1 8 6
pct_omit_in_rev_JAX   percentage of responses considered omissions (reversal learning assay), founders , reversal   110468 (F) 3 6 14 10 7 3 8 8
(M) 4 5 11 8 11 2 8 5
pct_omit_cc_acq_JAX   percentage of responses considered omissions (reversal learning assay), CC , acquisition   110497 (F) 3 6 14 8 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 2 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 2 7 8
(M) 4 5 10 8 2 3 3 1 2 2 1 2 3 1 2 1 4 2 2 4 1 3 2 4 3 1 1 2 1 3 3 2 2 1 1 2 4 1 2 1 1 3 2 1 2 10 1 8 6
pct_omit_cc_rev_JAX   percentage of responses considered omissions (reversal learning assay), CC , reversal   110498 (F) 3 6 14 10 3 4 2 1 2 2 1 1 2 2 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 2 3 2 1 1 2 4 1 3 1 2 3 1 2 2 7 3 8 8
(M) 4 5 11 8 2 4 3 2 2 2 1 2 3 1 2 1 3 3 2 4 1 3 2 4 3 1 1 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 5
pct_omit_do_acq_JAX   percentage of responses considered omissions (reversal learning assay), DO , acquisition   110527 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
pct_omit_do_rev_JAX   percentage of responses considered omissions (reversal learning assay), DO , reversal   110528 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
total_time_in_acq_JAX   total time for all trials (reversal learning assay), founders , acquisition   110469 (F) 3 6 14 10 8 3 9 8
(M) 4 5 11 8 11 2 8 6
total_time_in_rev_JAX   total time for all trials (reversal learning assay), founders , reversal   110470 (F) 3 6 14 10 8 3 9 8
(M) 4 5 11 8 11 2 8 6
total_time_cc_acq_JAX   total time for all trials (reversal learning assay), CC , acquisition   110499 (F) 3 6 14 10 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 3 9 8
(M) 4 5 11 8 2 4 3 2 2 2 1 2 3 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 6
total_time_cc_rev_JAX   total time for all trials (reversal learning assay), CC , reversal   110500 (F) 3 6 14 10 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 3 9 8
(M) 4 5 11 8 2 4 3 2 2 2 1 2 3 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 6
total_time_do_acq_JAX   total time for all trials (reversal learning assay), DO , acquisition   110529 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
total_time_do_rev_JAX   total time for all trials (reversal learning assay), DO , reversal   110530 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
trial_init_latency_in_acq_JAX   mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders , acquisition   110473 (F) 3 6 14 10 8 3 9 8
(M) 4 5 11 8 11 2 8 6
trial_init_latency_in_rev_JAX   mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders , reversal   110474 (F) 3 6 14 10 8 3 9 8
(M) 4 5 11 8 11 2 8 6
trial_init_latency_cc_acq_JAX   mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), CC , acquisition   110503 (F) 3 6 14 10 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 3 9 8
(M) 4 5 11 8 2 4 3 2 2 2 1 2 3 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 6
trial_init_latency_cc_rev_JAX   mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), CC , reversal   110504 (F) 3 6 14 10 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 3 9 8
(M) 4 5 11 8 2 4 3 2 2 2 1 2 3 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 6
trial_init_latency_do_acq_JAX   mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), DO , acquisition   110533 (F) 3 6 14 10 226 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
trial_init_latency_do_rev_JAX   mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), DO , reversal   110534 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
reward_time_in_acq_JAX   latency to retrieve reward per total correct responses (reversal learning assay), founders , acquisition   110477 (F) 3 6 14 10 8 3 9 8
(M) 4 5 11 8 11 2 8 6
reward_time_in_rev_JAX   latency to retrieve reward per total correct responses (reversal learning assay), founders , reversal   110478 (F) 3 6 14 10 8 3 9 8
(M) 4 5 11 8 11 2 8 6
reward_time_cc_acq_JAX   latency to retrieve reward per total correct responses (reversal learning assay), CC , acquisition   110507 (F) 3 6 14 10 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 3 9 8
(M) 4 5 11 8 2 4 3 2 2 2 1 2 3 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 6
reward_time_cc_rev_JAX   latency to retrieve reward per total correct responses (reversal learning assay), CC , reversal   110508 (F) 3 6 14 10 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 3 9 8
(M) 4 5 11 8 2 4 3 2 2 2 1 2 3 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 6
reward_time_do_acq_JAX   latency to retrieve reward per total correct responses (reversal learning assay), DO , acquisition   110537 (F) 3 6 14 10 226 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
reward_time_do_rev_JAX   latency to retrieve reward per total correct responses (reversal learning assay), DO , reversal   110538 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
antici_resp_left_in_acq_JAX   total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), founders , acquisition   110479 (F) 3 6 14 10 7 3 8 8
(M) 2 5 10 7 11 2 8 6
antici_resp_left_in_rev_JAX   total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), founders , reversal   110480 (F) 3 6 14 10 8 3 9 8
(M) 4 5 11 8 11 2 8 6
antici_resp_left_cc_acq_JAX   total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), CC , acquisition   110509 (F) 3 6 14 10 3 3 2 1 3 2 1 1 1 3 3 2 1 3 2 3 3 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 2 3 1 2 2 7 3 8 8
(M) 2 5 10 7 2 4 3 2 2 1 1 2 3 1 2 1 4 3 2 4 1 3 1 4 3 1 2 2 1 3 3 2 2 1 1 2 4 1 2 1 1 2 2 2 11 2 8 6
antici_resp_left_cc_rev_JAX   total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), CC , reversal   110510 (F) 3 6 14 10 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 3 9 8
(M) 4 5 11 8 1 4 3 2 2 2 1 2 3 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 6
antici_resp_left_do_acq_JAX   total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), DO , acquisition   110539 (F) 3 6 14 10 226 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
antici_resp_left_do_rev_JAX   total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), DO , reversal   110540 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
antici_resp_right_in_acq_JAX   total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), founders , acquisition   110481 (F) 3 6 13 10 8 3 8 8
(M) 4 5 11 7 10 2 7 6
antici_resp_right_in_rev_JAX   total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), founders , reversal   110482 (F) 3 6 14 10 8 3 9 8
(M) 4 5 11 8 11 2 8 6
antici_resp_right_cc_acq_JAX   total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), CC , acquisition   110511 (F) 3 6 13 10 3 3 2 1 3 2 1 1 2 3 3 2 1 3 2 2 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 4 1 3 1 1 3 1 2 2 8 3 8 8
(M) 4 5 11 7 2 4 3 2 2 2 1 2 2 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 2 2 2 1 2 5 1 2 1 1 3 2 2 10 2 7 6
antici_resp_right_cc_rev_JAX   total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), CC , reversal   110512 (F) 3 6 14 10 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 2 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 3 9 8
(M) 4 5 11 8 2 4 3 2 2 2 1 2 3 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 6
antici_resp_right_do_acq_JAX   total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), DO , acquisition   110541 (F) 3 6 14 10 226 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
antici_resp_right_do_rev_JAX   total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), DO , reversal   110542 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
antici_correct_in_acq_JAX   mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders , acquisition   110483 (F) 3 6 13 10 8 3 8 8
(M) 4 5 11 7 11 2 8 6
antici_correct_in_rev_JAX   mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders , reversal   110484 (F) 3 6 14 10 8 3 9 8
(M) 4 5 11 8 11 2 8 6
antici_correct_cc_acq_JAX   mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC , acquisition   110513 (F) 3 6 13 10 3 3 2 1 3 2 1 1 2 3 3 2 1 3 2 3 3 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 1 3 1 2 2 8 3 8 8
(M) 4 5 11 7 2 4 3 2 2 2 1 2 3 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 2 2 2 1 2 4 1 2 1 1 2 2 2 11 2 8 6
antici_correct_cc_rev_JAX   mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC , reversal   110514 (F) 3 6 14 10 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 2 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 3 9 8
(M) 4 5 11 8 1 4 3 2 2 2 1 2 3 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 6
antici_correct_do_acq_JAX   mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), DO , acquisition   110543 (F) 3 6 14 10 226 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
antici_correct_do_rev_JAX   mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), DO , reversal   110544 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
antici_incorrect_in_acq_JAX   mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders , acquisition   110485 (F) 3 6 14 10 7 3 8 8
(M) 2 5 10 7 10 2 7 6
antici_incorrect_in_rev_JAX   mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders , reversal   110486 (F) 3 6 14 10 8 3 9 8
(M) 4 5 11 8 11 2 8 6
antici_incorrect_cc_acq_JAX   mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC , acquisition   110515 (F) 3 6 14 10 3 3 2 1 3 2 1 1 1 3 3 2 1 3 2 2 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 4 1 3 1 2 3 1 2 2 7 3 8 8
(M) 2 5 10 7 2 4 3 2 2 1 1 2 2 1 2 1 4 3 2 4 1 3 1 4 3 1 2 2 1 3 3 2 2 1 1 2 5 1 2 1 1 3 2 2 10 2 7 6
antici_incorrect_cc_rev_JAX   mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC , reversal   110516 (F) 3 6 14 10 3 4 2 1 3 2 1 1 2 3 3 2 1 3 2 3 4 2 3 1 2 3 1 2 2 2 3 2 3 3 2 1 1 2 4 1 3 1 2 3 1 2 2 8 3 9 8
(M) 4 5 11 8 2 4 3 2 2 2 1 2 3 1 2 1 4 3 2 4 1 3 2 4 3 1 2 2 1 3 3 3 2 2 1 2 5 1 2 1 1 3 2 1 2 11 2 8 6
antici_incorrect_do_acq_JAX   mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), DO , acquisition   110545 (F) 3 6 14 10 226 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
antici_incorrect_do_rev_JAX   mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), DO , reversal   110546 (F) 3 6 14 10 227 8 3 9 8
(M) 4 5 11 8 154 11 2 8 6
trials_in_acq_Binghamton   total number of trials (reversal learning assay), founders , acquisition   112873 (F) 7 6 6 7 5 7 6 5
(M) 5 6 6 4 5 4 6 4
trials_in_rev_Binghamton   total number of trials (reversal learning assay), founders , reversal   112874 (F) 7 6 5 7 5 7 6 5
(M) 5 5 6 4 5 4 6 4
trials_cc_acq_Binghamton   total number of trials (reversal learning assay), CC , acquisition   112891 (F) 7 6 6 7 3 4 3 3 3 1 3 2 6 3 5 7 6 5
(M) 5 6 6 4 2 7 3 3 3 2 3 3 5 3 5 4 6 4
trials_cc_rev_Binghamton   total number of trials (reversal learning assay), CC , reversal   112892 (F) 7 6 5 7 2 4 3 3 3 3 2 6 3 5 7 6 5
(M) 5 5 6 4 2 7 3 2 3 2 3 3 5 3 5 4 6 4
diff_trials_rev_acq_in_Binghamton   reversal trials minus acquisition trials (reversal learning assay), founders   113852 (F) 7 6 5 7 5 7 6 5
(M) 5 5 6 4 5 4 6 4
diff_trials_rev_acq_cc_Binghamton   reversal trials minus acquisition trials (reversal learning assay), CC   113854 (F) 7 6 5 7 2 4 3 3 3 3 2 6 3 5 7 6 5
(M) 5 5 6 4 2 7 3 2 3 2 3 3 5 3 5 4 6 4
correct_in_acq_Binghamton   total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders , acquisition   112875 (F) 7 6 6 7 5 7 6 5
(M) 5 6 6 4 5 4 6 4
correct_in_rev_Binghamton   total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders , reversal   112876 (F) 7 6 6 7 5 7 6 5
(M) 5 6 6 4 5 4 6 4
correct_cc_acq_Binghamton   total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC , acquisition   112893 (F) 7 6 6 7 3 4 3 3 3 1 3 2 6 3 5 7 6 5
(M) 5 6 6 4 2 7 3 3 3 2 3 3 5 3 5 4 6 4
correct_cc_rev_Binghamton   total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC , reversal   112894 (F) 7 6 6 7 2 4 3 3 3 3 2 6 3 5 7 6 5
(M) 5 6 6 4 2 7 3 2 3 2 3 3 5 3 5 4 6 4
omit_in_acq_Binghamton   total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders , acquisition   112877 (F) 7 6 6 7 5 7 5 5
(M) 5 6 6 4 4 4 4 4
omit_in_rev_Binghamton   total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders , reversal   112878 (F) 7 6 6 7 5 7 4 5
(M) 5 5 6 4 5 4 5 4
omit_cc_acq_Binghamton   total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC , acquisition   112895 (F) 7 6 6 7 3 4 3 2 3 1 3 1 6 3 5 7 5 5
(M) 5 6 6 4 2 7 3 3 3 2 3 3 5 2 4 4 4 4
omit_cc_rev_Binghamton   total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC , reversal   112896 (F) 7 6 6 7 2 4 3 3 3 3 2 4 3 5 7 4 5
(M) 5 5 6 4 2 7 3 1 2 2 3 3 5 2 5 4 5 4
pct_correct_in_acq_Binghamton   percentage of responses that are correct (reversal learning assay), founders , acquisition   112879 (F) 7 6 6 7 5 7 6 5
(M) 5 6 6 4 5 4 6 4
pct_correct_in_rev_Binghamton   percentage of responses that are correct (reversal learning assay), founders , reversal   112880 (F) 7 6 5 7 5 7 6 5
(M) 5 5 6 4 5 4 6 4
pct_correct_cc_acq_Binghamton   percentage of responses that are correct (reversal learning assay), CC , acquisition   112897 (F) 7 6 6 7 3 4 3 3 3 1 3 2 6 3 5 7 6 5
(M) 5 6 6 4 2 7 3 3 3 2 3 3 5 3 5 4 6 4
pct_correct_cc_rev_Binghamton   percentage of responses that are correct (reversal learning assay), CC , reversal   112898 (F) 7 6 5 7 2 4 3 3 3 3 2 6 3 5 7 6 5
(M) 5 5 6 4 2 7 3 2 3 2 3 3 5 3 5 4 6 4
pct_omit_in_acq_Binghamton   percentage of responses considered omissions (reversal learning assay), founders , acquisition   112881 (F) 7 6 6 7 5 7 5 5
(M) 5 6 6 4 4 4 4 4
pct_omit_in_rev_Binghamton   percentage of responses considered omissions (reversal learning assay), founders , reversal   112882 (F) 7 6 5 7 5 7 4 5
(M) 5 4 6 4 5 4 5 4
pct_omit_cc_acq_Binghamton   percentage of responses considered omissions (reversal learning assay), CC , acquisition   112899 (F) 7 6 6 7 3 4 3 2 3 1 3 1 6 3 5 7 5 5
(M) 5 6 6 4 2 7 3 3 3 2 3 3 5 2 4 4 4 4
pct_omit_cc_rev_Binghamton   percentage of responses considered omissions (reversal learning assay), CC , reversal   112900 (F) 7 6 5 7 2 4 3 3 3 3 2 4 3 5 7 4 5
(M) 5 4 6 4 2 7 3 1 2 2 3 3 5 2 5 4 5 4
total_time_in_acq_Binghamton   total time for all trials (reversal learning assay), founders , acquisition   112883 (F) 7 6 6 7 5 7 6 5
(M) 5 6 6 4 5 4 6 4
total_time_in_rev_Binghamton   total time for all trials (reversal learning assay), founders , reversal   112884 (F) 7 6 6 7 5 7 6 5
(M) 5 6 6 4 5 4 6 4
total_time_cc_acq_Binghamton   total time for all trials (reversal learning assay), CC , acquisition   112901 (F) 7 6 6 7 3 4 3 3 3 1 3 2 6 3 5 7 6 5
(M) 5 6 6 4 2 7 3 3 3 2 3 3 5 3 5 4 6 4
total_time_cc_rev_Binghamton   total time for all trials (reversal learning assay), CC , reversal   112902 (F) 7 6 6 7 2 4 3 3 3 3 2 6 3 5 7 6 5
(M) 5 6 6 4 2 7 3 2 3 2 3 3 5 3 5 4 6 4
trial_init_latency_in_acq_Binghamton   mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders , acquisition   112885 (F) 7 6 6 7 5 7 6 5
(M) 5 6 6 4 5 4 6 4
trial_init_latency_in_rev_Binghamton   mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders , reversal   112886 (F) 7 6 6 7 5 7 6 5
(M) 5 6 6 4 5 4 6 4
trial_init_latency_cc_acq_Binghamton   mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), CC , acquisition   112903 (F) 7 6 6 7 3 4 3 3 3 1 3 2 6 3 5 7 6 5
(M) 5 6 6 4 2 7 3 3 3 2 3 3 5 3 5 4 6 4
trial_init_latency_cc_rev_Binghamton   mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), CC , reversal   112904 (F) 7 6 6 7 2 4 3 3 3 3 2 6 3 5 7 6 5
(M) 5 6 6 4 2 7 3 2 3 2 3 3 5 3 5 4 6 4
antici_correct_in_acq_Binghamton   mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders , acquisition   112887 (F) 7 6 5 7 5 5 5 5
(M) 5 6 6 4 4 4 5 4
antici_correct_in_rev_Binghamton   mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders , reversal   112888 (F) 7 6 6 7 5 4 6 5
(M) 5 6 6 4 5 4 6 4
antici_correct_cc_acq_Binghamton   mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC , acquisition   112905 (F) 7 6 5 7 3 4 2 3 3 1 2 2 6 3 5 5 5 5
(M) 5 6 6 4 2 6 3 2 3 2 3 3 5 3 4 4 5 4
antici_correct_cc_rev_Binghamton   mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC , reversal   112906 (F) 7 6 6 7 2 4 3 3 3 3 2 6 2 5 4 6 5
(M) 5 6 6 4 2 7 3 2 3 2 3 3 5 3 5 4 6 4
antici_incorrect_in_acq_Binghamton   mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders , acquisition   112889 (F) 7 5 5 6 5 6 4 4
(M) 4 6 5 4 5 4 6 4
antici_incorrect_in_rev_Binghamton   mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders , reversal   112890 (F) 7 6 5 6 5 7 6 5
(M) 5 6 6 4 5 4 6 4
antici_incorrect_cc_acq_Binghamton   mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC , acquisition   112907 (F) 7 5 5 6 3 4 3 2 3 1 2 2 6 3 5 6 4 4
(M) 4 6 5 4 1 6 3 2 3 2 3 3 5 3 5 4 6 4
antici_incorrect_cc_rev_Binghamton   mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC , reversal   112908 (F) 7 6 5 6 2 4 3 3 3 3 2 6 3 5 7 6 5
(M) 5 6 6 4 2 6 3 2 3 2 3 3 5 3 5 4 6 4
period_in   peak-to-peak interval, indicating amount of time it takes for one cycle of bioluminescence circadian rhythm, in fibroblast cultures, founders   112539 (F) 10 9 10 10 9 8 10 9
(M) 9 9 10 10 9 7 10 8
period_cc   peak-to-peak interval, indicating amount of time it takes for one cycle of bioluminescence circadian rhythm, in fibroblast cultures, CC   112544 (F) 10 9 10 10 2 2 1 2 4 2 3 5 3 2 2 3 2 5 3 2 1 1 4 1 1 4 1 1 2 1 2 9 8 10 9
(M) 9 10 10 10 1 2 2 3 2 2 6 6 2 2 3 3 2 2 4 3 1 6 1 1 2 1 3 1 1 2 10 7 10 8
phase_in   specific time point when bioluminescence reaches highest circadian rhythm amplitude (cycle number), in fibroblast cultures, founders   112540 (F) 10 9 10 10 9 8 10 9
(M) 9 9 10 10 9 7 10 8
phase_cc   specific time point when bioluminescence reaches highest circadian rhythm amplitude (cycle number), in fibroblast cultures, CC   112545 (F) 10 9 10 10 2 2 1 2 4 2 3 5 3 2 2 3 2 5 3 2 1 1 4 1 1 4 1 1 2 1 2 9 8 10 9
(M) 9 10 10 10 1 2 2 3 2 2 6 6 2 2 3 3 2 2 4 3 1 6 1 1 2 1 3 1 1 2 10 7 10 8
amplitude_in   peak-to-trough, indicating level of synchronization in circadian rhythm (max counts/s), in fibroblast cultures, founders   112541 (F) 10 9 10 10 9 8 10 9
(M) 9 9 10 10 9 7 10 8
amplitude_cc   peak-to-trough, indicating level of synchronization in circadian rhythm (max counts/s), in fibroblast cultures, CC   112546 (F) 10 9 10 10 2 2 1 2 4 2 3 5 3 2 2 3 2 5 3 2 1 1 4 1 1 4 1 1 2 1 2 9 8 10 9
(M) 9 10 10 10 1 2 2 3 2 2 6 6 2 2 3 3 2 2 4 3 1 6 1 1 2 1 3 1 1 2 10 7 10 8
damping_in   number of days required for circadian rhythm amplitude to decrease to 36% of initial value, in fibroblast cultures, founders   112542 (F) 10 9 10 10 9 8 10 9
(M) 9 9 10 10 9 7 10 8
damping_cc   number of days required for circadian rhythm amplitude to decrease to 36% of initial value, in fibroblast cultures, CC   112547 (F) 10 9 10 10 2 2 1 2 4 2 3 5 3 2 2 3 2 5 3 2 1 1 4 1 1 4 1 1 2 1 2 9 8 10 9
(M) 9 10 10 10 1 2 2 3 2 2 6 6 2 2 3 3 2 2 4 3 1 6 1 1 2 1 3 1 1 2 10 7 10 8
goodness_of_fit_in   percentage of observed rhythms that fit expected sine wave, indicating stability and robustness of circadian rhythm, in fibroblast cultures, founders   112543 (F) 10 9 10 10 9 8 10 9
(M) 9 9 10 10 9 7 10 8
goodness_of_fit_cc   percentage of observed rhythms that fit expected sine wave, indicating stability and robustness of circadian rhythm, in fibroblast cultures, CC   112548 (F) 10 9 10 10 2 2 1 2 4 2 3 5 3 2 2 3 2 5 3 2 1 1 4 1 1 4 1 1 2 1 2 9 8 10 9
(M) 9 10 10 10 1 2 2 3 2 2 6 6 2 2 3 3 2 2 4 3 1 6 1 1 2 1 3 1 1 2 10 7 10 8